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ON THE STRUCTURE AND FUNCTION OF MITOCHONDRIAL 
UNCOUPLING PROTEINS: THE CASE OF UCP2 
 
Uncoupling proteins (UCPs) are regulated proton transporters of the mitochondrial inner 
membrane. UCP-mediated proton leak negatively impacts the rate of ATP synthesis. Despite the 
importance of their physiological role(s) in certain tissues, molecular aspects of UCPs’ structure-
function relationships are not fully understood. The current study explores the tertiary and 
quaternary structure of UCP2, as well as its proton transport mechanism in lipid membranes. The 
proteins were expressed in the E. coli inner membrane, purified and reconstituted into liposomes. 
Proteins were characterized by semi-native SDS-PAGE. Circular dichroism spectroscopy (CD) 
and fluorescence quenching assays were utilized to study the conformation of proteins and evaluate 
their proton transport function, respectively. Molecular dynamics (MD) simulations were 
performed in parallel to investigate the protein structure and some details of its proton transport 
function at atomic and molecular levels. 
To study the structure of UCP2, the protein was purified both as monomers and as a mixture 
of monomers, dimers, and tetramers in detergent micelles. After reconstitution, UCP2 associated 
into functional tetramers regardless of the original oligomeric/molecular form that was used for 
reconstitution. Computational analysis suggested that the functional tetramer is in fact a 
pseudosymmetrical dimer of dimers capable of inducing asymmetry in the membrane structure. 
Tetrameric UCP2 had a biphasic conformation in which the orientation of cavities of monomers 
in each dimeric unit was similar but opposite to the monomers of the other dimeric unit.  The 
differences in cavity orientations within a tetramer is consistent with an alternating access 
mechanism. Based on this mechanism, in order to transport their substrates, the cavity of 
mitochondrial carrier proteins opens to the matrix and intermembrane space alternately.  
Two salt-bridge networks, one close to the matrix (matrix network) and the other close to 
the intermembrane space (cytoplasmic network) have been previously suggested to play important 
roles in the alternating access mechanism. The UCP2 matrix network was modified in multiple 
ways using point mutations of K→Q, D→N, K→D and D→K (resulting in either partial or full 
disruption or inversion of the network by switching the two ends of salt-bridges) and the 
consequences of these modifications on proton transport and its inhibition by ATP were analyzed.  
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The matrix network had a filtering role in proton transport of UCPs and evidence is provided 
that the network may consist of more salt-bridges than have been previously suggested (five vs. 
three). A biphasic proton transport model is proposed for tetrameric UCP2 in which the 
conformation of each functional dimer is either in one or the other mode of transport, acting as an 
on/off switch. ATP could interact with all positive residues of the matrix network (K38, K141, 
K239, R88, R185, R279) and thus interfere with the alternating open and close modes of the 
protein’s cavity. 
 Overall, this thesis provides new insights into the tetrameric structure of UCP2 and the 
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CHAPTER 1 - BACKGROUND INFORMATION 
1.1 Mitochondria 
Mitochondria are organelles surrounded by two membranes, which play multiple vital 
functions in eukaryotic cell metabolism and beyond [1]. Mitochondria play a pivotal role in cellular 
bioenergetics by producing ATP via oxidative phosphorylation (OXPHOS). Mitochondria are also 
involved in the β-oxidation of fatty acids, synthesis of nucleotides, as well as  synthesis of heme 
and iron-sulfur clusters [1]. Beyond metabolism, mitochondria regulate propagation of signals for 
a diverse set of biological outcomes such as calcium (Ca2+) homeostasis, gene expression, cellular 
differentiation and cell death [1].  
1.2 Mitochondrial membrane compartments 
Inner and outer membranes of mitochondria separate this organelle from the cytosol [2]. The 
outer membrane of mitochondria (OMM) is porous; small molecules and ions can pass through 
OMM porins, and as a result of this permeability no membrane potential/voltage can be formed 
across the OMM [2]. In contrast to the OMM, only specific ions and molecules can be transported 
across the inner membrane of mitochondria (IMM) through membrane protein (MP) channels and 
transporters [2]. The selectivity of transporters and channels generates an electrochemical potential 
across the IMM (discussed below in detail) [2]. 
Three distinct aqueous zones can be distinguished in a mitochondrion: (i) matrix, the 
innermost aqueous mitochondrial zone which is characterized by a low proton concentration (pH 
= 7.9-8) [3]; (ii) intermembrane space (IMS), a ~200 Å wide aqueous space between the IMM and 
OMM (pH = 7.2-7.4) [2]; and (iii) cristae, which are the tubular, lamellar or bag-like invaginations 
of the IMM that extend into the matrix (Figure 1-1, A)  [2].  The higher pH of the matrix compared 
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to IMS drives the ATP synthesis [3]. The IMM can be subdivided into two domains with distinct 
function and protein composition: (i) the boundary membrane, which is parallel (and close) to the 
OMM, and (ii) the cristae membrane (Figure 1-1, A) [4]. The boundary and cristae membranes are 
continuous; the transition between the two domains of the IMM occur at the site of cristae junctions 
(narrow slits at the entrance of the cristae [4]).  
Cristae are the main site of cellular respiration in all eukaryotes, as the complexes of the 
electron transport chain (ETC) and ATP synthase are present in cristae membrane (Figure 1-1, A-
B), and cytochrome c (the small soluble protein that carries electrons) is present in cristae lumen 
(the region of the IMS that is constrained within an IMM cristae) [2]. Cristae are anchored to the 
OMM through mitochondrial contact sites and cristae organizing system (MICOS) [5]. MICOS is 
an assembly of six (one soluble and five membrane) proteins. It has been proposed that MICOS 
provides a barrier for lateral diffusion of the proteins between cristae and the boundary membranes 
and restricts the movement of protons [2, 6]. The observation that individual cristae have different 
membrane potentials could be the result of restricted movement of protons out of the cristae lumen 
[6]. 
1.3 Mitochondria are referred to as the powerhouse of the cell 
 In order to produce consumable energy molecules (ATP) that can be used to drive 
metabolic processes in the cell, the tricarboxylic acid (TCA) cycle [7] (also known as the citric 
acid cycle or Krebs cycle) and OXPHOS take place in mitochondria [8]. The final product of lipid, 
sugar, or amino acid catabolism, acetyl-coA, enters the Krebs cycle upon interaction with 
oxaloacetate (a four-carbon molecule) in the mitochondria matrix to form a six-carbon citrate 
molecule. After seven subsequent enzymatic steps, oxaloacetate will be regenerated and can then 
re-enter the cycle to receive another molecule of acetyl-CoA [9]. During the Krebs cycle, the two 
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carbons from the acetyl group of acetyl-coA are released in the form of two CO2 molecules, and 
the extra electrons are passed to nicotinamide adenine dinucleotide (NADH) and flavin adenine 
dinucleotide (FADH2) to be carried to the ETC, a series of protein complexes located in the IMM 
(Figure 1-1, C)  [8]. 
The passage of electrons from NADH and FADH2 molecules to the ETC components 
triggers the efflux of protons from the matrix to the IMS, thus generating an electrochemical 
gradient across the IMM widely known as the proton motive force [10] that eventually results in 
formation of ATP by the aid of ATP synthase complex [10]. 
Complex I of the ETC, NADH dehydrogenase, is a 1 MDa protein complex with a binding 
site for NADH in the matrix [11].  Donation of two electrons from NADH to complex I leads to a 
series of oxidation-reduction reactions throughout the iron-sulfur clusters within the protein which 
result in transfer of the electrons to coenzyme Q, a lipophilic redox carrier [8]. A consequence of 
the passage of electrons through complex I is a conformational change which ultimately causes 
pumping of four protons from the matrix to the IMS [8]. The other electron carrier generated during 
the Krebs cycle, FADH2, carries two electrons to the complex II of the ETC, called succinate 
dehydrogenase [8]. Similar to complex I, complex II passes the electrons to coenzyme Q through 
iron-sulfur clusters.  However, unlike complex I, complex II does not pump protons to the IMS [8] 
(Figure 1-1, C). 
After accepting electrons from complex I or II, Coenzyme Q transfers the electrons to 
complex III, cytochrome c reductase [8]. Cytochrome c reductase oxidizes coenzyme Q and passes 
the two accepted electrons to two cytochrome c molecules (one electron per cytochrome c) (Figure 
1-1, C) [8]. Two protons are liberated to the IMS as a result of oxidation of Coenzyme Q and two 
additional protons are pumped from the matrix to the IMS upon reduction of cytochrome c. 




Figure 1-1 Structural and functional elements of cristae. A) Three-dimensional representation of cristae shows 
the presence of an array of ATP synthase dimers (yellow and orange). B) Movement of protons into and out of the 
IMS by the aid of protein complexes. ETC complexes (light purple) pump protons (red circle) from the matrix into 
the IMS. Some other proteins in the IMM such as uncoupling protein (UCP, orange), phosphate carrier (PIC, 
yellow), aspartate/glutamate carrier (AGC, green), ADP/ATP carrier (AAC, blue) and Na+/H+ transporter (NHE, 
dark purple) relocate protons back to the matrix. Black arrows show the direction of movement of protons. C) 
Complexes of the ETC pass the electrons forward (black arrows) and pump the protons up to the IMS resulting in 
formation of proton motive force and synthesis of ATP by ATP synthase. D) Function of selected proton 
transporters of the IMM. AAC, UCP, PIC, AGC are not necessarily monomers, the monomeric form is shown for 
simplicity. Figure generated by ChemBioDraw Ultra 14.0. 




Each cytochrome c molecule donates one electron to complex IV, cytochrome c oxidase. 
Four cytochrome c enzymes transfer four electrons to complex IV, where the last step of the ETC 
takes place [8]. Complex IV passes the four electrons to one molecule of oxygen (O2) to produce 
two molecules of H2O (Figure 1-1, C).  Parallel to this reduction, four protons are pumped across 
the IMM to the IMS from the matrix (Figure 1-1, C) [8].  
Complexes of the ETC can oligomerize in different arrangements and stoichiometries [12]. 
For example, a copy of complex I, two copies of complex III and a copy of complex IV can come 
together in the IMM to form a 1.7 MDa supercomplex called the respirasome [13]. It has been 
recently shown that the oxidoreductase activity of complex I increases up to three times upon 
formation of respirasomes [14]. As a result of this finding, researchers suggest that formation and 
dissociation of supercomplexes such as respirasomes can be a cellular response to ATP demand 
and to control reactive oxygen species (ROS) formation [14]. At low concentrations of ATP, 
respirasomes are formed to increase the enzymatic efficiency of complex I, and thereby increase 
electron and proton flux. Conversely, at high ATP concentrations respirasomes dissociate to 
decrease electron transport, and thus decrease the risk of ROS formation [14].  
The consequence of translocation of protons from the matrix to the IMS in different steps of 
the ETC is the generation of a ~200 mV electric potential across the IMM [8]. After the Krebs 
cycle and ETC, the resulting electrochemical gradient across the IMM is transformed into a more 
readily consumable form of energy for the cell through a “coupling” process. Coupling of the 
electrochemical gradient to ATP synthesis was first proposed by Peter Mitchell in 1961 [10], who 
won the Nobel Prize in chemistry for the discovery 17 years later. ATP synthase (also known as 
complex V and F0F1 ATPase) provides a route for protons to flow in accordance with their 
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concentration gradient from the IMS to the matrix. The outcome of this passage is conformational 
changes in ATP Synthase that result in ATP synthesis from ADP and Pi [8]. The mechanism of 
ATP synthesis was hypothesized and developed by Paul Boyer and John Walker from 1964 to 
1994, for which they were awarded the Nobel Prize in chemistry in 1997 [15]. It is estimated that 
the transport of between 2-5 protons are needed for the synthesis of one molecule of ATP. 
However, relating these numbers to the number of required NADH or FADH2 is not 
straightforward as protons can leak across the IMM through routes other than the ATP synthase 
complex. Three ATP per one NADH or two ATP molecules per one FADH2 are common 
estimations [8]. Eukaryotic ATP synthase macromolecules are arranged as linear arrays of dimeric 
complexes found in narrow cristae ridgelines or near tight tubular cristae [16]. (Figure 1-1, A-B)  
Not only protons, but also electrons can leak across the IMM. Leakage of electrons from 
different complexes of the ETC, other than complex IV, can lead to reduction of O2 to superoxide 
radical anions [8]. Most intracellular ROS are formed from superoxide [17]. Even though low 
levels of ROS are important for cell function, high levels of ROS can cause oxidative stress [17].  
Oxidative stress is a condition where ROS production is uncontrollable by the antioxidant defense 
system of a cell [18]. Oxidative stress has multiple deleterious effects in cells, including causing 
chemical damage to proteins, lipids and nucleic acids, as well as apoptosis [18]. 
1.4 Uncoupling of oxidative phosphorylation 
Translocation of protons that are pumped into the IMS during the electron transport process 
back to the matrix results in dissipation of the electrochemical gradient across the IMM, and thus 
uncouples electron transport from ATP synthesis [19]. 
Proton leak across the IMM is the outcome of two leakage processes: basal and inducible 
proton leak [20]. Basal proton leak is non-regulated leakage of protons across the IMM, which 
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depends on the fatty acyl composition of the membrane and the presence of mitochondrial carriers 
that are able to translocate protons [such as ADP/ATP carrier (AAC), also known as adenine 
nucleotide translocase (ANT)]. (Figure 1-1, B and D) [20, 21]. Inducible proton leak is controlled 
by a specific family within the mitochondrial carrier superfamily (MCF) known as “Uncoupling 
Proteins” (UCPs) (Figure 1-1, B and D) and can be regulated by fatty acids, superoxides, lipid 
peroxidation products and adenine nucleotides [21].  
UCP1 (thermogenin, the prototypic member of the UCP family), was discovered in 1978 by 
Heaton et al. in hamster [22], and was purified from brown adipose tissue of rat and hamster 
mitochondria in high yields by Lin and Klingenberg within two years of its discovery [23]. Almost 
20 years after the discovery of  UCP1, four other homologues of UCPs were discovered: UCP2 
(1997) [24, 25], UCP3 (1997) [26, 27], UCP4 (1999) [28], and UCP5 (1998) [29]. 
UCPs have different expression patterns in the human body. UCP1 is mainly found in brown 
fat adipose tissue [19]. UCP2 is expressed in several tissues such as skeletal muscles, heart, liver, 
kidney, lung, pancreas, spleen, and macrophages [19]. UCP3 is mostly expressed in brown adipose 
tissue and muscles [19]. UCPs 4 and 5 are specifically neuronal and mainly expressed in brain 
tissues [19]. UCPs 2, 4 and 5 are considered as neuronal UCPs, as they are predominantly found 
in the central nervous system (CNS) [30].  
In addition to protons, UCPs transport a wide spectrum of ions including (but not limited to) 
monovalent anions such as chloride, bromide, nitrate [31, 32] and alkyl sulfonates [33]. It is 
reported that UCP2 is able to transport anionic C4 metabolites such as aspartate, malate and 
oxaloacetate [34]. 
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1.4.1 ROS regulation at mitochondrial level  
Mitochondria contribute significantly to the production of cellular ROS [35]. Approximately 
1 to 2% of the oxygen utilized by mitochondria results in the productions of superoxide anion 
(O2
•¯) [35]. In cases where excess ROS generation leads to oxidative stress, mitochondria 
overexpress UCPs [36]. The evidence for the preventive role of UCPs against oxidative stress has 
been discussed in many studies [36-38]. UCPs activity may also decrease the rate of apoptosis 
(programmed cell death) induced by ROS species [36]. These proteins can be activated by 
superoxide anions, resulting in the dissipation of the electrochemical gradient across the IMM [35]. 
Overall, UCPs are considered to contribute in a feedback loop which is activated by ROS, and 
leads to decrease in superoxide concentration [35, 36].  
1.4.2 Thermoregulation at the neuronal level 
Among UCPs, UCP1 is known to have a thermogenic physiological function in brown 
adipose tissues. It has also been shown that neuronal UCPs can increase the temperature in 
neuronal microenvironments during uncoupling activity [39]. As neuronal UCPs mostly 
accumulate in axon terminals, their thermogenesis can lead to changes in neurotransmission 
mechanisms [39]. It has been suggested that temperature differences between neuronal cells in the 
absence and presence of UCPs result in a temperature gradient that facilitates the diffusion of 
neurochemicals toward their postsynaptic targets [40]. Furthermore, although UCPs decrease the 
amount of synthesized ATP per mitochondrion, these proteins trigger mitochondria biogenesis, 
thereby raising overall cellular ATP levels. Higher cellular ATP concentrations in presynaptic 
nerve terminals, where UCP is present, assist active processes (such as formation, transportation 
and exocytosis of vesicles), and consequently facilitates neurotransmission [39, 40].  
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1.4.3 Calcium uptake regulation   
Mitochondria can modulate the Ca2+ content of intact cells via uptake and release 
mechanisms, which are carried out separately. Mitochondrial ATP production and metabolism can 
be regulated by Ca2+ uptake activity in the IMM, which is mostly performed by the mitochondrial 
Ca2+ uniporter (MCU) [41]. The fundamental role of UCPs in regulating MCU activity has been 
reported in intact cells and in isolated liver mitochondria [42]. However, the involvement of UCPs 
in regulation of Ca2+ transporters remains controversial [43, 44]. Using gene silencing in human 
and mice cell lines, Trenker et al. [43] showed that UCPs 2 and 3 could affect both the amount and 
the rate of Ca2+ uptake [43]. Additionally, it has been proposed that UCPs can act as conductive 
ion channels for Ca2+ [41, 43]. 
1.5 Mitochondrial carrier family 
Solute carrier proteins (SLCs) are integral MPs, responsible for transport of solutes across 
intracellular membranes [45]. The largest family of SLCs in the human body is the MCF or SLC25 
with 53 members [46]. MCF proteins are mostly antiporters, transporting different solutes across 
the IMM in opposite directions. Some MCF proteins are uniporters, transporting solute molecules 
in one direction, whereas others are thought to be substrate-proton symporters [46]. Because of 
amino acid sequence similarities among the MCF members it has been suggested that these 
proteins have comparable secondary and tertiary structures [47, 48].  
1.5.1 Structural features of the MCF members 
Most of what is known about the structure of MCF members is based on knowledge of AAC, 
which is the most characterized member of the MCF. AAC is the only member of the MCF for 
which high resolution x-ray structures are available [49, 50] (Figure 1-2, A-F). The first AAC x-
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ray structure was of bovine AAC1 (BtAAC) (2003) (PDB ID: 1OKC) [49]. AAC imports ADP 
from the IMS into the matrix and exports ATP from the matrix to the IMS [50].  
The structure of AAC reveals a trilateral pseudosymmetric structure that includes 3 tandem 
repeats. Each repeat is composed of ~100 amino acids distributed into two transmembrane (TM) 
α-helices that are connected by a hydrophilic short helix parallel to the membrane on the matrix 
side [49] (Figure 1-2, A and D).   
1.5.1.1 Matrix and cytoplasmic gates 
Two conserved signature motifs are present at the water-membrane interface of 
mitochondrial carrier proteins. The first signature motif, PX[DE]XX[RK], is located on odd 
numbered helices (helices 1, 3 and 5) close to the matrix side [49, 51]. The matrix salt-bridge 
network (or matrix network) is formed as a result of electrostatic interactions between positive 
and negative residues of the matrix side signature motifs [49, 51] (Figure 1-2). Conserved 
glutamine residues, known as the Q-brace/glutamine-brace, located in close proximity to the 
matrix signature motif  (Px[DE]xx[KR]xxxQ) on helices 1 and/or 3 and/or 5 provide extra 
structural support by forming hydrogen bonds with the salt-bridge network residues [46] (Figure 
1-2).  
The second signature motif, [FY][DE]XX[RK], is located on even numbered helices (helices 
2, 4 and 6) close to the IMS. Just like the matrix network, an intramolecular salt-bridge network is 
also formed from electrostatic interactions of positively and negatively charged residues of the 
signature motifs close to the IMS, known as the cytoplasmic salt-bridge network (cytoplasmic 
network) [51].  The cytoplasmic network is supported by hydrogen bond formation between 
tyrosine residues that are in the motif with the residues of the cytoplasmic network (Y 
brace/tyrosine-brace). MCF members have one to three of each brace (Q or Y) [46] (Figure 1-2).  




Figure 1-2 Overall structure and conserved functional residues of AAC. A) X-ray structure of bovine AAC in 
the cytoplasmic state (1OKC). The conserved functional residues are shown as spheres. B) Detailed representation 
of the side chains and directions of conserved residues of bovine AAC. C) Top view of broken cytoplasmic and 
formed matrix networks of bovine AAC in the cytoplasmic state. D) X-ray structure of TtAAC in the matrix state 
(6GCI). The conserved functional residues are shown in spherical format. E) Detailed representation of the side 
chains of TtAAC. F)  Top view of the broken matrix and formed cytoplasmic networks of Tt AAC in the matrix 
state. Figure generated by USCF Chimera 1.13rc 
 
1.5.1.2 Single Binding site  
Based on the structure of AAC1 it has been proposed that a single conserved common 
substrate/inhibitor/solute binding site (SBS) is present at the center of the transporter cavity in all 
MCF members (Figure 1-2) [48]. This binding site resides at the bottom of a solvent accessible 
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cavity and includes three protein-substrate specific contact points at even numbered helices [52, 
53].  It has been suggested that contact points I (located on helix 2) and II (located on helix 4) can 
confer substrate specificity to the carrier; however, it seems that the positively charged contact 
point III (located on helix 6) does not contribute to substrate specificity [46] (Figure 1-2).   
1.5.1.3 πGπXπG and πXXXπ motifs 
Besides signature motifs, there are other sequences that are conserved between the members 
of MCF, such as the πGπXπG motif on helices 1, 3 and 5 and the πXXXπ motif on helices 2, 4 and 
6 [50]. The symbol π refers to amino acids with short side chains; however, occasionally amino 
acids with bulky side chains might be found at the π positions [46]. These two motifs contribute 
to the function of the protein which will be discussed in the next section [50]. 
1.5.2 Functioning via a comparable alternating mechanism 
Comparable amino acid sequences and the presence of conserved motifs led some 
researchers to suggest that all members of the MCF transport their respective solutes (substrates) 
via an alternating access mechanism [46, 54]. In this hypothesized mechanism, mitochondrial 
anion carriers can adopt two different conformational states: a cytoplasmic state (V), in which the 
solvent accessible cavity of the carrier is open towards the IMS (like the letter “V”); and the matrix 
state (Λ), in which the solvent accessible cavity of the carrier is open towards the matrix side (like 
the symbol “Λ”) [52]. Members of the MCF can alternate between matrix and cytoplasmic states 
by movement of the helices towards or away from the central Z axis (normal to the bilayer) as a 
consequence of substrate binding [50] (Figure 1-3). 




Figure 1-3 Alternating access mechanism is proposed to be a common mechanism for substrate translocation by 
members of the MCF. In this model the protein’s cavity opens alternately towards the cytoplasmic and matrix sides 
alternatively. Figure generated in PowerPoint 365. 
 
Matrix and cytoplasmic salt-bridge networks and Q and Y braces are important structural 
features that contribute to stabilizing the protein conformation in each state [55]. It has been 
hypothesized that in the cytoplasmic state (V) all three salt-bridges of the matrix network are 
formed, thereby narrowing the matrix-facing side of the cavity, while the salt-bridges of the 
cytoplasmic network are all broken; this state is in contrast to the matrix state (Λ) during which it 
has been hypothesized that the cytoplasmic salt-bridge network is fully formed and the matrix salt-
bridge network is broken [51].  Until 2019, the reported structures of different isoforms of AAC 
(AAC1-4) in different organisms were all locked in the cytsoplasmic state [49, 55] (Figure 1-2, A-
C). In 2019, Ruprecht et al. (50) published a structure of yeast (Thermothelomyces thermophila) 
AAC (TtAAC) locked in the matrix state (Figure 1-2, D-F). Availability AAC structure (from 
different sources) locked in matrix and cytoplasmic states further supports the alternating access 
hypothesis. The small size of the residues of the conserved motifs πGπXπG and πXXXπ allows 
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the helices to come close to one another in the matrix state (Λ), assisting the cytoplasmic network 
to form [50]. Furthermore, the aromatic residues of the signature motif, plus aromatic and bulky 
residues in the vicinity of the IMS in the cytoplasmic state, provide a ~15 Å shield to oppose 
uncontrolled proton leak through the protein in the cytoplasmic state [56]. The amino acids that 
are believed to participate in the formation of these proton gates are conserved among all MCF 
members [46].  
1.6 Proton transport/leak across the IMM by MCF proteins 
Among members of the MCF, a few are known to transport protons across the IMM. Other 
than UCPs, of which proton transport is the common regulated function [21], most other 
transporters of protons are in fact anion carriers, which use the proton (gradient) as a driving force 
to co-transport other substrates across the IMM [57]. Substrate-proton co-transport by some MCF 
proteins is accomplished mainly by symport or antiport mechanisms [52, 57]. Section 1.6 provides 
structural and mechanistic information about the regulated proton leak by UCPs and non-regulated 
proton leak by other members of MCF. Due to similarity of the proposed mechanisms of MCF 
members, one example of each transport mode (symport and antiport) will be discussed in detail. 
The list of human MCF proton leakers of the IMM, along with their respective amino acid 
sequences and transport modes (symport or antiport), can be found in Figure A-1-1. The sequence 
alignments were generated using Jalview [58]. The conserved elements involved in the alternating 
access mechanism are marked at the top of the respective columns.  
1.6.1 Regulated proton transporters of IMM: Uncoupling proteins 
As mentioned above, UCPs are the only subfamily of the MCF known to be responsible for 
regulated proton leak across the IMM [21]. Because of low purification yield and numerous 
preparation steps (such as extraction from membrane, purification in native form and reconstitution 
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in a bilayer mimicking environment) analyses of structure and function of MPs have always been 
difficult and controversial [59]. UCPs are good examples of such controversies. Researchers 
disagree on UCPs’ mechanism of function and inhibition [60-63], as well as their tertiary [59, 64] 
and quaternary structures [65-68]. Even though there is no available x-ray structure for UCP 
homologues, structures of UCP1 [69] and UCP2 (PDB ID: 2LCK) (Figure 1-4) [70] have been 
obtained by NMR spectroscopy. The reported structures of UCPs 1 and 2 possess the common 
structural features of MCF proteins; however, the internal cavity in UCP monomers is higher 
compared to what is commonly observed in other members of the MCF [59]. Despite 
disagreements on structure and function, activation of UCPs by fatty acids and their inhibition by 
purine nucleotides are generally accepted [60, 71].  
 
Figure 1-4 Structure of UCP2 in cytoplasmic state. A) sideview, B and C) top view, residues involved in the 
cytoplasmic and matrix salt-bridge networks are shown in blue and red, respectively. Figure generated by USCF 
Chimera 1.13rc.  
 
Proton flux by UCPs is activated by fatty acids [30, 71]. Evaluation of the effect of fatty acid 
features (length, structural rigidity, hydrophobicity) on proton transport rate of neuronal UCPs 
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reveals that unsaturated and long chain fatty acids are generally more potent proton transport 
activators [30, 32]. Alterations of circular dichroism (CD) spectra of neuronal UCPs reconstituted 
in phosphatidylcholine (PC) vesicles upon addition of fatty acids imply that fatty acids are able to 
induce conformational changes in UCPs [30]. NMR spectroscopy of UCP1 and 2 suggests that 
there is a groove between helices 1 and 6, which might be a fatty acid binding site; the hydrophobic 
chain of the fatty acid lays in the groove and its headgroup faces the matrix side [63, 69]. Hoang 
et al. [32] also proposed the presence of a specific geometrically optimized binding site for fatty 
acids in UCPs 2, 4 and 5. Furthermore, mutagenetic and functional analysis of UCPs by different 
researchers and different methods provide important insights about fatty acid-UCP interactions, as 
well as residues that are involved in UCP-mediated transport. Table 1-1 shows the residues that 
are involved in proton transport regulation along with the major findings of related studies [30, 32, 
48, 63, 69, 70, 72-76].  
Three models have been proposed to describe the role of fatty acids in activation of proton 
transport of UCP/UCP1: (i) fatty acid cycling model [61]; (ii) buffering/cofactor model [62]; and 
(iii) proton shuttling model [73] (Figure 1-5). In the fatty acid cycling model, a (protonated) fatty 
acid that resides in the IMS is transferred to the matrix through a “flip-flop” process across the 
lipid bilayer and releases its proton to the matrix. Transport of the fatty acid anion back from the 
matrix to the IMS is then facilitated by UCP (Figure 1-5) [61]. NMR results from Zhao et al. [69] 
are compatible with the cycling model. In the buffering model, fatty acid anions bind to UCP and 
accept/donate protons via their carboxylate group from and to titratable amino acids of the 
translocon channel (the central channel of the carrier), all the way to the matrix side, where the 
proton is released (Figure 1-5) [60, 62]. The shuttling model proposes that the proton transport 
mechanism depends on the length of the fatty acid; short chain protonated fatty acids can be 
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transported from the IMS to the matrix (where they release their proton) via UCPs’ translocon 
channel, whereas long chain fatty acids remain in the translocation channel. Long chain fatty acids  
 
Table 1-1 Residues involved in proton transport regulation and the major findings of related studies. 
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1-The fatty acid chain probably partitions 
into a groove between helices 1 and 6 
which is likely its binding site and the 
carboxylate head group interacts with R60 
and K271. 
2- Fatty acid flipping is required for H+ 
transport activity of UCP2. 
3-GDP can allosterically dislocate fatty 










There is a specific binding site between 







 -patch clamp 
of whole 
mitoplast 
1- Proposed induced fit mechanism 
(shuttling model + alternating access) 
2-Long chain low pKa fatty acid anions 
can inhibit proton transport thus transport 
of proton and fatty acid is from the same 
translocation path. 
[72, 73] 





Single point mutations of R84Q, R183T 
and R277L resulted in more than 93% 
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1-Longer fatty acids showed better 
transport rate: PA>MA>LA 
2-Sensitivity of mutants to fatty acid 
length was different: 
K104Q>R96Q>>UCP2 
3-R76Q and R88Q decreased the chloride 
transport rate up to 82-83%. 
4-Succinic acid (C4) did not activate 
proton transport of UCP2. 
[32] 
UCP2   -fluorescence Addition of fatty acid inhibited UCP2 
inherent chloride transport up to ~50%, 
suggesting that fatty acids and chloride 
ions (anions) share the same path. 
[30] 
UCP1 Single binding site: D28, R84, R183, S184, I187, S230, R277 
(Found based on sequence alignment with AAC) 
[52] 
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remain bound to the protein while their head group moves back and forth across the IMM (getting 
protonated in the IMS and releasing the proton into the matrix) (Figure 1-5) [73].  
In addition to the three “UCP specific” mechanisms of proton transport, as a member of the 
MCF, UCPs also share the structural features necessary for an alternating access mechanism 
(Figure 1-2). Consequently, alternating access could be considered a fourth potential model for the 
mechanism of proton transport by UCPs. Even though the three arginine residues of the proposed 
single binding site (in the alternating access mechanism) cannot be the binding site for long chain 
fatty acids (as they are polar and have symmetrical arrangement compared to the asymmetric 
structure of fatty acids) [51], these arginine residues could attract the fatty acid from the IMS [51]. 
In 2017, an updated version of the shuttling model [induced transition fit model (ITF)] was 
proposed by Bertholet et al. [72]. In this model, the elements of alternating access have been 
combined with the shuttling mechanism. Based on this ITF model, the arginine residues of the 
single binding site (R84, R13, R277) of UCP1 attract long chain anionic fatty acids towards the 
cavity of the protein where D28 is present [72]. Proximity of the anionic fatty acid’s head and D28 
will result in increasing the pKa of both fatty acid and aspartate residue leading to attraction of a 
proton from the IMS. Co-presence of fatty acid and proton in the cavity will lead to further 
conformational changes from the cytoplasmic to matrix state at which point the proton gets 
released into the matrix [72] (Figure 1-5).  




Figure 1-5 Proposed mechanisms of proton transport by UCPs.  In the fatty acid cycling model, protonated 
fatty acid (yellow head group and a black tail) flip-flops across the lipid bilayer, releases its proton (green circle) 
and is transported from to the IMS as an anion by UCP. In the buffering model, fatty acid anion binds to UCP and 
accepts/donates protons via its carboxylate group from and to titratable amino acids of the translocon channel. In 
the shuttling model long chain fatty acids remain bound to the protein while their head moves back and forth across 
the IMM (getting protonated in the IMS and releasing the proton into the matrix). In the alternating access model 
(or ITF), UCP changes conformation from cytoplasmic to matrix state and vice versa upon movement of fatty acid 
across the translocon channel. Figure generated by PowerPoint 365. 
 
None of these models are universally accepted and there are arguments in support and against 
all of them [60]. Fatty acids are not the only compounds that are able to activate UCPs; superoxides 
and alkenals (lipid peroxidation products) such as HNE (4-hydroxy 2-nonenal) can also activate 
UCPs [77]. It has been demonstrated that superoxides activate UCPs from the matrix side and that 
they are also sufficient for UCP activation [78].  
Di- and tri-phosphate purine nucleotides (ADP, ATP, GDP, and GTP) inhibit UCPs’ proton 
flux activity [79]. The degree of inhibition of UCPs by purine nucleotides is different; for example, 
UCP2 is more inhibited by ATP compared to ADP [80]. The mechanism of inhibition by purine 
nucleotides is not fully known yet; but the current working model for inhibition is based on 
mutational studies on UCP1. These studies indicated that three arginine residues are essential in 
binding of GDP by UCP1: R84, R183, and R277 [74]. Single mutations of R183T and R277L 
resulted in loss of more than 90% of proton transport inhibition without any changes in the 
uninhibited rate of transport. A single mutation of R88Q caused 99% loss of inhibition, while the 
proton transport rate doubled [74]. The three R residues are conserved among all human UCPs and 
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also make up part of the single SBS [based on homology/sequence alignment with other members 
of MCF (Table 1-1)] [52]. It has been demonstrated that addition of purine nucleotides to UCPs 
reconstituted in lipid vesicles induces minor changes in the protein’s overall conformation [80, 
81]. One NMR study of UCP2 showed that GDP could broaden NMR resonances on helices 1, 2, 
3 and 4 [70], which means that GDP interacts with these helices [82].  This study suggested that 
R185 and K141 of UCP2 can interact with GDP [70]. A complementary study by the same group 
added R88 to the list of GDP-interacting residues [63]. Interestingly, two out of the three amino 
acids were among those that have been shown to interact with fatty acid as well (Table 1-1) [63]. 
One suggested inhibitory mechanism of GDP is that it can bind inside the translocation channel of 
the protein and allosterically displace fatty acid from its binding site [63]. 
There are different reports about the stoichiometry of UCP inhibition by purine nucleotides; 
some have concluded that inhibition is achieved by one nucleotide per monomer [83], while others 
suggest the stoichiometry is one nucleotide per dimer [84].  
In addition to protons, all UCP homologues are able to transport chloride [80]. However, the 
rate at which UCPs transport chloride ions is lower compared to that of protons, also no fatty acid 
is needed to initiate chloride transport [80, 30]. In fact, fatty acids inhibit UCPs chloride transport 
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1.6.2 Non-regulated proton leak 
1.6.2.1 ADP/ATP carrier  
AAC is an antiporter of ADP and ATP across the IMM. As a result of the conversion between 
the cytoplasmic and matrix states, AAC transports around a human body weight of ADP and ATP 
per day [50]. Two inhibitors of AAC, carboxyatractyloside (CATR) [85] and bongkrekic acid 
(BKA) [86, 87], are able to lock the structure in cytoplasmic and matrix states, respectively.  
The structural elements that are involved in the alternative access mechanism can all be seen 
in the crystal structures of the carrier [46, 50] (Figures 1-2 and A-1-1).  
i) Matrix network three salt-bridges (K33-D232, R235-D135 and R235-E30) and the Q-
brace (Q37) from BtAAC, V; 
ii) The cytoplasmic network salt-bridges (D299-K208, D205-K104 and D101-Q302) and 
the Y brace Y298, Y204 (and R100) from TtAAC, Λ; 
iii) The SBS residues R88, G192 and R287 for TtAAC and R80, G183 and R 280 for 
BtAAC.  
After the matrix state structure was reported by Ruprecht et al. (Figure 1-2) [50], the same 
researchers proposed a detailed mechanism of transport, which is in agreement with the previously 
proposed alternating access mechanism [50]. In this mechanism, matrix and cytoplasmic 
conformational states can be interconverted as a result of interconnected movement of the helices 
(between 12-17 Å) towards the central z-axis of the carrier or away from it [56]. It has also been 
proposed that the SBS has minimal movement during the conversion of the two conformational 
states and is accessible from either side [56]. In fact, the contact points appear to act as a fulcrum 
during conformational changes [50, 56].  
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A comparison of CATR-locked (V) and BKA-locked (Λ) structures reveals that only 20% 
of the carrier structure changes during the interconversion of the two conformational states. [50]. 
One notable change is the movement of cytoplasmic ends of the even numbered helices resulting 
in formation or disruption of the cytoplasmic network [50]. Surface analyses of the cytoplasmic 
and matrix states are in agreement with the two-state alternating access mechanism, as in each 
state the exposed site provides a positively charged accessible surface available for ATP or ADP 
binding; conversely, the opposite side is closed at the same time with no/very low positively 
charged surface available for interaction [50].  
The proposed transport mechanism of AAC is very thorough and detailed [50], however, it 
suggests that non-solvent accessible gates in both cytoplasmic and matrix states prevent the proton 
leak across the protein. However, AAC has long been known to be able to transport protons from 
the IMS to the matrix [21, 88, 89]. A recent patch-clamp study of mouse AAC in mitoplasts 
(mitochondria with the OMM removed) provides valuable insights into this carrier’s proton 
transport mechanism [90], which is consistent with, yet complementary to, the mechanism 
proposed by Ruprecht et al. [50]. In this patch-clamp study, AAC was shown to be capable of 
transporting protons only in the presence of micromolar concentrations of fatty acids on the 
cytosolic/IMS side [90]. In the proposed mechanism, fatty acid functions as a co-factor bound to 
the carrier, and its carboxylate head moves through the translocation pathway. Therefore, 
inhibitors of the translocation pathway (CATR and BKA) inhibit the AAC mediated proton 
transport [90]. Fatty acid can bind to the carrier regardless of its initial conformational state (matrix 
state or cytoplasmic state), and proton transport cannot induce any changes in the carriers’ 
conformational state [90]. Furthermore, translocation of ADP and ATP by AAC decreases the 
proton transport activity. Based on these studies it has been hypothesized that AAC functions via 
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two transport modes both sharing the same translocation path: (i) ADP/ATP antiporter mode based 
on the alternating access mechanism (cytoplasmic state and matrix state interconversions [46]), 
and (ii) proton transport mode, which relies on presence of/ activation by fatty acids [90].  
1.6.2.2 Proton driven symporters: phosphate carrier  
One example of a proton-driven symporter among MCF members is the mitochondrial 
phosphate carrier (PIC) [91].  PIC is responsible for stoichiometric symport of phosphate and 
protons from the IMS into the matrix; as a result of this symport, inorganic phosphate will be 
available for ATP synthesis in the matrix [92]. Like many other members of the MCF, no high-
resolution structure is available for PICs and there is no consensus on the mechanisms of transport. 
Symport of proton and phosphate [92], antiport of OH and phosphate [92], fatty acid cycling model 
for the proton transport function [93] and MCF alternating access mechanism [57] are among the 
proposed mechanisms of PIC function.  
As shown in Figure 1-6, A, three amino acids (Q227, R226 and D177) are present in the 
binding site of human PIC (SLC25A3) and play a role in the co-transport of protons and phosphate 
molecules [57]. It has been shown that the carriers which are thought to symport substrate and 
protons across the IMM, all possess a negatively charged residue in close proximity to positive 
residues in their contact points [57]. In the case of human PIC, the positively charged R226 can 
provide a potential binding site for the anionic phosphate; however, aspartic acid residue  




Figure 1-6 Mechanism of nonregulated proton co-transport across PIC and AGC. A) residues involved in 
substrate co-transport of PIC (the residues in the parentheses are human counterparts of the studied Candida 
albicans residues) B) schematic structure of active (calcium bound) dimeric AGC1. Ca2+ binding results in 
formation of a hydrophobic groove for binding of C-terminal α-helix (purple). This movement results in activation 
of glutamate and proton transport. C) residues involved in substrate co-transport of AGC1 (the residues in the 
parentheses are human counterparts of the studied Saccharomyces cerevisiae residues). This figure is copied from 
refs. [57] and [94] with permission, minor changes applied. 
 
at position 177 could prevent this substrate binding in two ways: (i) by electrostatically pushing 
back the phosphate group, or (ii) by interacting with Q180 and R179, thereby decreasing the 
affinity of the cationic contact site to bind to the negative substrate (Figure 1-6, A) [57]. Co-
transport of a proton with phosphate neutralizes D177, and not only cancels the two preventive 
roles of aspartate but can also assist the transport of the substrate against its gradient using the 
proton motive force [57]. When the PIC is in the cytoplasmic state the contact points are 
available/exposed for interacting with the substrate. Nonetheless, the aspartate residue of PIC 
cannot be protonated in the absence of phosphate even in high proton concentrations of the IMS, 
as the Arginine residue will keep Aspartate’s pKa low (~4) [57]. While the phosphate group 
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interacts with R226 and Q227 the negative charges of phosphate and aspartate will drive the proton 
towards the binding site by electrostatic attraction. Furthermore, the additional electrostatic 
interactions resulting from co-transport of a proton provides the energy needed to disrupt the 
matrix network [57]. Consequently, the carrier can change its conformation and opens towards the 
matrix side (cytoplasmic to matrix state conformational change) and the phosphate and proton can 
be released into the matrix [57].  
1.6.2.3 Proton driven antiporters: aspartate/glutamate transporter 
Aspartate/glutamate carriers 1 and 2 (AGC1 and AGC2) are examples of MCF antiporters 
with the ability to co-transport protons across the IMM [95]. Human AGC1 and AGC2 are encoded 
by SLC25A12 and SLC25A13 genes, respectively [95]. These carriers transport the aspartate 
which is synthesized in the mitochondrial matrix to the IMS in exchange for glutamate which is 
co-transported with a proton [95]. AGCs have ~675 amino acid residues which are divided into 8 
N-terminal EF-hands in the IMS (~330 amino-acids) [94] plus a C-terminal domain of ~340 
amino-acids [96]. The C-terminal domain is composed of a TM domain structurally similar to 
other MCF members [52] and a further ~40 amino acid soluble domain in the IMS (Figure 1-6, B) 
[94]. AGCs are believed to be dimeric [94]. Upon binding of Ca2+, the EF-hands 1 and 2 can partly 
move to open a hydrophobic groove to permit the cytosolic α-helix of the C-terminal to bind [94]. 
As a result of these movements glutamate and a proton can concomitantly enter the TM domain to 
induce the conformational changes (cytoplasmic to matrix state) leading to transport of the 
substrates (Figure 1-6, B) [94, 95].  
As shown in Figure 1-6, C, the residues involved in the AGC1 binding site are E402 and 
K403, R490 and D491.  Under physiological pH, E402 can repel IMS glutamate as a result of 
repulsion between the two sidechain negative ions [48]. However, co-transport of a proton with 
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glutamate might result in neutralization of E402, thereby facilitating binding of glutamate to K403 
[48]. This is very similar to what happens in the co-transport of phosphate and proton through PICs 
[57]. The difference is that AGC is a proton-driven exchanger, whereas the PIC is a proton driven 
co-transporter/symporter. Translocation of aspartate from matrix to IMS is gradient driven, 
meaning that it is facilitated by the higher concentration of aspartate in the matrix, the weak 
cytoplasmic salt-bridge network (with a low energy barrier to overcome), and the membrane 
potential [57].  
It has been shown that when the concentration of Ca2+ in the IMS increases the rate of 
electron transport also increases up to 5 times, as the proton gradient will constantly be dissipated 
by AGC activity [95]. The decrease in the membrane potential by AGC activity might also result 
in reducing ROS production because of the inverse relationship between the membrane potential 
and ROS production [97].  
 
Figure 1-7 Rocking bundle model and elevator model are both sub-categories of the alternating access model 
for transport. These models are proposed for sodium and proton translocation by CPA1 and CPA2 families, 
respectively. In the rocking bundle model, the core domain has ~7 Å rocking motion and in the elevator model, the 
core domain rotates ~21° and shift ~10 Å. Both models lead the substrate SBS to become alternatively accessible 
to two different sides of the membrane. Figure generated by PowerPoint 365. 
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1.6.2.4 Non-proton driven antiporter: Ornithine/citrulline carrier  
The mitochondrial ornithine/citrulline (ORC) exchanger is another proton translocator of the 
MCF [98]. However, in contrast to all other proton transporters in this family, proton translocation 
by ORC occurs against its concentration gradient and therefore requires energy [98]. The ORC 
carrier transports cytosolic ornithine across the IMM to the matrix in exchange for a citrulline 
molecule and a proton [98]. The energy required for this translocation could be provided by 
favorable gradients of the substrates across the IMM [98]. Since ornithine is positively charged in 
physiological pH, the net charge transfer resulting from the activity of this transporter is zero [98]. 
Ornithine and citrulline molecules are involved in urea synthesis. Citrulline is synthesized from 
ornithine in the matrix and transferred to the cytosol where it enters the urea cycle [99] via ORC 
[98]. In the urea cycle, urea is formed, citrulline is converted back to ornithine, and ornithine re-
enters the matrix via ORC [100]. Two human isoforms of ORC have been discovered to date: 
ORC1 and ORC2 [101]. Even though ORC isoforms share 87% sequence identity, they have 
differences in substrate specificity; ORC2 is less specific compared to ORC1 [102]. 
A mutagenesis study of ORC1 and ORC2 shows that residue 179 is important in substrate 
specificity [102]. In the case of ORC1, ornithine binds to residues E180, R179 and E77 [102]. 
Close proximity of R179 to the matrix salt-bridge network might imply that R179 can also play a 
role in the ORC1 conformational change resulting in its transformation from cytoplasmic state to 
matrix state [102]. 
1.7 Proton leak in mitochondria by non-MCF members 
In addition to the MCF members that are responsible for translocation of a wide range of 
substrates (such as, nucleotides, coenzymes and various ions) across the IMM, other 
carriers/channels are also present in the IMM which translocate cations [103]. Most studied of 
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these transporters are MCU (which is responsible for unidirectional import of Ca2+ into the matrix 
[104, 105]), Na+/Ca2+  exchanger (NCLX) (which allows influx of Na+ into the matrix and efflux 
of Ca2+ to the IMS [106]), as well as K+/H+ and Na+/H+ exchangers (KHE and NHE) (which 
translocate protons into the matrix in exchange for cytosolic K+ and Na+, respectively [107, 108]). 
Both NHE and KHE are able to translocate protons across the IMM; however, NHE is more active 
[109].  
NHEs are members of the cation-proton antiporter (CPA) family [110]. Due to slow rate of 
electrochemical gradient-driven leakage of Na+ (and K+) cations across the IMM, mitochondria 
would never survive without transporters such as NHE (and KHE) to expel the cations out of the 
matrix [109]. NHEs are not exclusive to the mitochondria [111]. In fact, ten isoforms of NHEs 
(NHE1-NHE10) are differentially expressed in various tissues of the human body [111]. NHEs 1, 
2 and 6 are reported to function in mitochondria. Among these, NHE6 is exclusively found in 
mitochondria [108, 111].  
Members of the CPA family can be subdivided into CPA1 and CPA2 carrier subgroups. 
CPA1 carriers exchange one proton against one Na+. Human NHEs are in the CPA1 branch [112]. 
CPA2 members exchange two protons against one Na+ [112]. It has been proposed that the 
conformational changes leading to translocation of ions across the membrane is the same among 
CPA1 and CPA2 members [112].  
Two models have been proposed for ion translocation by NHEs, which are both subclasses 
of the alternative access mechanism and both suggest a single site for ion-translocation: (i) the 
rocking bundle model, proposed based on structural analysis of a CPA1-type transporter, the 
Methanocaldococcus jannaschii NHE [112]; and (ii) the elevator model, proposed based on 
structural analysis of a member of the CPA2 sub-group, a NHE from Thermus thermophilus [113]. 
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NHEs have been shown to be dimers, where the monomeric subunits are composed of 12 or 
13 TM domains (CPA1: 13 [112], and CPA2: 12 [113]). The TM domains of each monomer are 
divided into a 6-helix bundle domain (core domain), which moves during the transport of ions, and 
a set of seven or six helices located at the dimer’s interface (dimerization domain), which is 
stabilized in the membrane and does not move during transport [112, 113] (Figure 1-7). 
In the rocking bundle model, the binding site becomes alternatively accessible to the two 
sides of the membrane upon a ~7 Å rocking motion of the core domain [112]. In the elevator 
model, a ~21° rotation of the core domain results in closure of the cavity on one side and opening 
of the cavity on the other side of the membrane. Parallel to this rotation, the core domain also shifts 
~10 Å towards the side which will be exposed next [113]. 
Even though the details behind the conformational changes are not known, two aspartate 
residues  (D156 and 157 on helix 5) are found in the binding site of the T. thermophilus NHE, 
which are highly conserved in all NHEs and have been shown to play a crucial role in the function 
of these proteins [113]. 
1.8 Disagreements about the functional forms of MCF members in lipidic environments 
Formation of homo- and/or hetero-oligomers in the membrane to optimize/regulate protein 
functions is common among MPs [68, 114, 115]. Therefore, understanding oligomerization and 
interconversion between different oligomeric states can provide insights about a protein’s 
mechanism of function [115]. An important example of oligomerization in the IMM is formation 
of the supercomplexes involved in the OXPHOS process [12], with different arrangements and 
stoichiometries. Lipids can influence and control protein oligomerization in the membrane [115]. 
The role of lipids in controlling oligomerization have been shown to be more important in MPs 
with weakly interacting subunits and small oligomerization interface(s) (small buried surface area 
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and no salt-bridge formation between the subunits) [114].  For example, NHEs of E. coli (no salt-
bridges between the subunits, buried surface area: 684.4 Å2) and T. thermophilus (two salt-bridges, 
buried surface area: 1800.9 Å2) both form dimers in membranes. However, the former carrier 
protein can dimerize only in the presence of cardiolipin (CL) because of its small buried surface 
area and lack of inter-subunit salt-bridges [114] while the latter do not need lipids for dimerization 
[114]. It has also been suggested that cells can alter lipid composition of the membranes to regulate 
the presence and abundance of oligomeric species [114].  
The quaternary structure and protein-lipid interactions of members of the MCF are not fully 
understood and in many cases researchers do not agree on the quaternary structures [66, 68, 116, 
117]. Some reports suggest that all mitochondrial carriers function as monomers [67, 116], while 
others propose a dimeric structure for many of them [117]. Among proton transporters of the MCF, 
there has not been universal agreement on the functional molecular forms of AAC [67, 118, 119], 
UCP [65-68] and PIC [67, 117, 120]. It has been demonstrated that CL is tightly bound to AAC 
and PIC and is considered to be required for the transport function of these proteins [118]. UCP 
has no tightly bound CLs [118]; however, the presence of CL in UCPs 2,4 and 5 lipidic 
environment affects their proton and chloride transport function and enhances their helical 
conformation [80]. It has been suggested that AAC is either a monomer [67] or a dimer [118], or 
both [121] in the membrane.  Out of six molecules of CL that are bound to subunits of dimeric 
AAC, two are thought to sit at the interface of the monomeric subunits and act as a “glue” [118]. 
Furthermore, it is suggested that CL might have a role in cross-talk between AAC subunits in the 
dimer [118]. Moiseeva et al. [121] showed that external factors (such as tonicity of the 
mitochondria or incubation at 4° C) can influence the oligomerization of AAC [121]. PICs are also 
proposed to function either as a monomer [67] or dimer [120].  
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The case of UCPs is more complicated, since monomeric [83], dimeric [65] and tetrameric 
[30, 68, 80] structures have been reported to be functional.  A dimeric functional form was the first 
reported quaternary structure for UCP1 [65]. It has been shown that UCPs might be able to interact 
with other members of the MCF, such as AAC, to form hetero-dimers [122]. Also, different 
homologues of UCPs are proposed to be able to interact with one another and form hetero-dimers, 
such as UCP2+UCP3 [42]. It has been suggested that homo-tetrameric MPs are most probably 
formed by dimerization of dimers [30, 68, 123]. 
The presence of a GXXXG motif on TM helices has been shown to be involved in homo- 
oligomerization of MPs as a result of helix-helix interactions [124]. This motif was first shown to 
play an important role in dimerization of glycophorin A [125]. NMR structure of the glycophorin 
A showed that two glycine residues, that are apart from one another by three amino acid residues, 
form a groove that allows the helices to pack closely [126]. Furthermore, the GXXXG motif is 
known to be the most abundant sequence involved in helix-helix association of E. coli inner MPs 
(~80%) [124, 127]. In addition to GXXXG, πXXXπ (π = small residues such as G, A, S or T) and 
GXXXAXXG have also been shown to play an important role in oligomerization of proteins [124]. 
On the other hand, such oligomerization motifs are very abundant MPs and cannot be used as the 
only source for prediction of dimerization interface [124]. 
1.9 Research goal and objectives 
The overall objective of this PhD dissertation is to provide novel insights into the structure 
and proton transport function of UCPs in lipid membranes. In order to accomplish this objective, 
two research goals are investigated: 
1- The functional structure of UCPs in the membrane; and  
2- The mechanism of proton transport by UCPs. 
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UCP2 was used as a model to answer these questions for several reasons: (i) its widespread 
expression in several mammalian tissues [19]; (ii) it has been shown to have multiple roles in 
mammals [41, 128, 129]; (iii) its high amino acid sequence identity with UCP1 (the prototypical 
UCP) [60]; and (iv) the availability of an atomic NMR structure [70]. 
1.9.1 Investigation of the functional structure of UCP2 in lipid environment 
The hypothesis for the first goal was that UCPs could exist and function as a tetramer (dimer 
of dimers), as well as monomers and dimers in the IMM. The support for this hypothesis came 
from the previous observation that several UCP homologues reconstituted in lipid vesicles as 
functional tetramers [30, 68]. In order to evaluate this hypothesis, four specific aims were pursued 
to: (i) separately purify and characterize UCP2 as monomers as well as a mixture of monomers, 
dimers, and tetramers, and to reconstitute these two group of molecular forms (monomer and 
mixture) in liposomes; (ii) compare the structure and function of the reconstituted proteins that 
originated from these two groups of proteins (monomer and mixture); (iii) investigate the structural 
features (such as the overall shape and dimensions of the subunits), and the physicochemical 
characteristics of tetrameric UCP2 (such as dissociation energy of the tetramer and dynamics of 
the subunits) in lipidic environments; (iv) better understand the factors that stabilize the oligomeric 
structure of UCP2, such as inter-subunit salt-bridges or bound lipids. 
To achieve these goals, UCP2 was expressed in the E. coli inner membrane and extracted 
first with lauryldimethylamine oxide (LDAO) detergent, which was switched at a later stage to a 
mild detergent (octyl glucopyranoside, OG) in its micellar form. Recombinant UCP2 was then 
purified in OG in two forms: as monomers and as a mixture of monomeric, dimeric, and tetrameric 
forms using immobilized metal affinity chromatography (IMAC). These two batches of proteins 
were then separately reconstituted in egg yolk PC vesicles using the detergent removal method to 
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study the structure and function of the protein in an environment that closely mimics the IMM 
[130, 131]. The structure and molecularity of UCP2 was then analyzed both in OG and large 
unilamellar vesicles (LUV) by far-UV CD spectroscopy [132] and semi-native sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) techniques [68]. The function of UCP2 
was studied using a fluorescence quenching assay [32, 68, 133]. The conformational features of 
the protein and the molecular interactions involved in oligomerization, were assessed by MD 
(Molecular Dynamics) simulations and related techniques [134]. Similar experimental and 
computational analyses were performed on AAC, (a structurally comparable MCF member for 
which the atomic x-ray structure is available) to validate our methods and compare the behavior 
of two proteins in lipid membranes. 
Collectively, this part of the research provided in-depth information about the possible 
structures of UCP2 in the IMM, local conformational changes of the monomeric subunits upon 
tetramerization and the process of oligomerization. It is shown that UCP tetramerizes in the 
membrane as a dimer of dimers in which the monomers in one dimeric pair have comparable 
conformations that are different from the monomers in the other dimeric pair. The outcome of the 
experiments done to address the first specific objective imply that the subunits of the UCP2 interact 
and influence one another in the regulation of the proton transport function of the tetramer. 
1.9.2 Evaluation of the mechanism of proton transport by UCP2 
The second project focused on analysis of proton transport by UCP2 via the proposed 
“alternating access mechanism” [51]. The hypothesis was that the matrix network in UCP2 plays 
a crucial role in regulation of proton transport. UCP2 has an overall net charge of +15, and a 
cluster of positive charges are accumulated close to the matrix side of the protein. High charge 
density at the matrix interface could contribute to the formation of an electric field (potential-
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sensitive area) that is capable of reacting to movement of charges/charged substrates and induction 
of conformational changes, which could contribute to substrate transport [32, 80]. Furthermore, 
the matrix network is in close proximity of three arginine residues (R88, R185 and R279) which 
have been suggested to be involved in inhibition and activation of UCPs in several studies [63]. 
The role of the matrix salt-bridge network in proton transport by UCP2 was studied through 
five specific aims: (i) Incorporate point mutations into UCP2 designed to partially or fully disrupt 
the matrix salt-bridge network; (ii) Test the integrity of the UCP2 matrix network by introducing 
three pairs of point mutations (6 mutations total) that maintain the integrity of the salt-bridges but 
switch the two ends of each bridge; (iii) compare the structures of UCP2 and its mutants in mild 
detergent (OG) and liposomes to ensure that the overall conformation of the native protein has 
been maintained in the mutants; (iv) compare the proton transport rate of UCP2 and its mutants in 
the presence and absence of purine nucleotide inhibitors; and finally (v) analyze and relate the 
proton transport function of UCP2 and its mutants to local conformational changes of the native 
protein.  
To achieve these goals, UCP2 and its eleven mutants were expressed in E. coli membranes, 
purified, and reconstituted in vesicles using the same methods as in the first project. Conformations 
and conformational stabilities of the UCP2 and its mutants in OG detergent were evaluated by far- 
and near-UV CD and thermal denaturation techniques [132]. Proton transport rates were analyzed 
by a fluorescence quenching assay [80, 133], and molecular and atomic details of the structures 
were analyzed by MD simulation methods [134]. 
Overall, the second project provides detailed information about the proton transport 
mechanism of tetrameric UCP2 and its regulation. This part of the study led to the proposal of a 
biphasic model for proton transport by UCP2. Based on this model, protons can pass through the 
CHAPTER 1 – BACKGROUND INFORMATION 
35 
 
central channels of monomeric subunits with the help of fatty acids via an alternating access 
mechanism. The two monomers within each dimeric unit are proposed to be in a similar 
stage/phase of transport (although not necessarily conformationally equivalent), but the dimeric 
units themselves are in opposite phases (when one is absorbing protons the other is releasing 
protons). Additionally, the monomeric subunits are not conformationally equivalent and their 
perpetual conformational changes could have a potential role in regulation of proton transport by 
influencing the neighboring subunits.




CHAPTER 2 - METHODOLOGIES 
2.1 Experimental Methodologies 
2.1.1 Recombinant overexpression and extraction of membrane proteins 
The natural abundance/quantity of MPs is usually not sufficient for in vitro biochemical and 
biophysical analyses; therefore, researchers usually have to use overexpression techniques to 
produce enough material for their studies [135]. Obtaining properly folded pure proteins in high 
yields has always been a challenge in MP research [135]. Considering the crucial role of lipidic 
environments on the structure and function of MPs, it would be preferable to directly express these 
proteins in cell membranes, such as bacterial membranes [114, 115]. The most widely used host 
for overexpression of MPs is E. coli; however, the membrane expression yield of eukaryotic MPs, 
such as UCPs, in E. coli is not always satisfactory [136]. Approaches to address this issue can be 
classified into three categories [136]: 
2.1.1.1 Engineering E. coli cells to make them more suitable for membrane protein 
expression 
Alteration of E. coli cells to favor MP overexpression has been used in several studies. One 
strategy is to reduce the rate of protein production to better fit the capacity of the cell biogenesis 
machinery and to ensure that the produced proteins are folded and integrated properly in the 
membrane [136, 137]. There are several procedures for slowing the rate of protein expression, one 
of which is to reduce the production and/or activity of RNA polymerase [136]. Widely used MP 
expression strains C41(DE3) [138], C43(DE3) [138], and Lemo21(DE3) [135, 137] are examples 
of strains of E. coli that produce lower levels of RNA polymerase [137]. Reduction of protein 
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expression rate can also be achieved by lowering the incubation temperature, the concentration of 
inducer, or strength of the vector [136]. 
Overexpression yield of MPs can also be increased by improving the ability of E. coli cells 
to localize the protein in the membrane [136]. Co-expression of chaperones and/or other proteins 
that are involved in targeting MPs to the membrane [139] or increasing membrane fluidity for 
easier insertion [140] have proven to be successful methods for achieving higher MP expression 
yields. 
2.1.1.2 Engineering the protein of interest to improve its yield of overexpression in the 
membrane 
Another way to increase MP expression yield is to modify the N- or C-terminus of the protein 
[136]. Most MPs contain an N-terminal (or internal) sequence that directs the protein to the 
membrane [136]. Shortening the N-terminal [141] or changing its properties by incorporating point 
mutations can impact the expression yield of MPs [142]. Furthermore, fusion of leader sequences 
to N- or C-termini of proteins can result in membrane targeting [136]. Membrane targeting 
sequences from Mistic (a membrane-associated protein from Bacillus subtilis) [143], SUMO (a 
small ubiquitin-related modifier) [143, 144], and pectate lyase B (pelB) [145, 146] have all been 
shown to enhance yields of recombinant MPs in E. coli by directing proteins to the bacterial 
membrane. PelB is a 22-residue signal peptide first characterized in Erwinia carotovora [146]. 
This leader sequence has been shown to target soluble proteins to the E. coli cell membrane for 
export to the periplasm and to direct several MPs to the E. coli inner membrane [68, 145, 147, 
148]. 
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2.1.1.3 Using expression hosts other than E. coli 
The reason behind the popularity of E. coli as a recombinant protein expression host is its 
ease of cultivation and availability of various genetic tools and biological methods for introduction 
of desirable changes [136]. Thus, other than convenience, there is no good reason for choosing E. 
coli as the only model organism for MP expression. Bacteria with more copies of MP chaperones 
(such as Bacillus subtilis) and/or slower growth rate (such as Lactococcus lactis) are promising 
alternatives to E. coli for overexpression of integral MPs, especially for those with multiple TM 
domains (more complicated folding) [136]. Furthermore, various eukaryotic hosts such as different 
yeast species, insect and mammalian cells can be used for expression of membrane proteins 
[60,72]. Throughout this thesis, E. coli has been used as the only host for expression of UCP2. 
Close homology relationship between gram negative bacteria and mitochondria makes E. coli a 
proper expression hosts for mitochondrial proteins. In fact, mitochondria are thought to have 
originated from gram negative bacteria about 1.6 million years ago [2].  
  Monitoring the cellular location of the overexpressed protein (either membrane or inclusion 
bodies or both), its quality and quantity are necessary steps in optimization of protein expression 
[136]. Fractionation of the host cells (to inclusion bodies, membrane fraction and soluble fraction) 
followed by determination of the protein abundance by SDS-PAGE and Western blot are common 
quality control steps of expression. Green fluorescent protein labeling could also be used for 
visualization of the protein in the whole cell [136]. 
2.1.1.4 Extraction and reconstitution of overexpressed membrane protein 
Once overexpressed, MPs should be extracted from host cells using a system that mimics 
the membrane and stabilizes the protein in its native form [149]. MPs are usually extracted from 
the membrane using detergent micelles [149]. Once extracted and purified, the purity of the protein 
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should be evaluated. Denaturing, semi-native and native PAGE analyses are common methods to 
visualize and estimate the purity of proteins. The concentration of SDS in sample loading and 
running buffers are 2.5% (w/v) and 35 mM, respectively, in denaturing SDS-PAGE. These 
concentrations decrease to 1% (w/v) and 2 mM in semi-native conditions [68], while there is no 
SDS (neither in sample loading buffer nor in the gel and running buffer) in native PAGE analyses 
[150]. Semi-native and native conditions maintain inter-subunit interactions thus allowing 
visualization of oligomers [68]. After purification, detergents can be removed and replaced by 
more stabilizing molecules such as amphipols, or the MPs can be reconstituted into lipid bilayers 
that mimic membrane environments such as bicelles, liposomes and nanodiscs [149]. Figure 2-1 
provides a summary of membrane mimetics that are frequently used in MP research. 
 
 
Figure 2-1 Schematic representation of various systems used for mimicking membrane environments. TM 
helices of MPs are shown in yellow. Lipids are shown in blue. Detergents in micelles and bicelles, amphiphilic 
polymers in amphipols, membrane scaffold proteins in nanodiscs and styrene maleic acid polymers in SMALP are 
all shown in red. Figure generated by ChemBioDraw Ultra 14.0. 
 
Each membrane mimetic system has its own pros and cons. One important advantage of 
detergents is that their interference with spectroscopic analysis is minimal [132]. On the down 
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side, detergents cannot preserve all of the surrounding lipids around MPs and cannot fully mimic 
the MP lipidic environment in terms of packing constraint, charge, shape and size; consequently 
they can significantly impact/alter the structure and function of the native proteins [132]. 
Amphipols are amphipathic polymers composed of a polyacrylate backbone with 
hydrophobic and hydrophilic sidechains capable of solubilizing MPs by adsorbing onto their 
surface [151, 152]. Amphipols can better stabilize the structure of MPs compared to detergents, 
and modification of the sidechains provide the opportunity to optimize them for specific studies 
and introduce labels; yet lack of actual lipidic environment around the MPs is still an issue [149]. 
In liposomes and bicelles, the purified MP is reconstituted in a synthetic bilayer mimetic, 
which allows the protein to be studied in the presence of lipids and to analyze the effect of changes 
in the lipidic environment on a protein’s structure and function [149, 153]. Large liposomes and 
bicelles usually interfere with spectroscopic analysis and special considerations should be taken 
into account [132, 149]. Furthermore, bicelles are usually unstable and can only be formed with 
limited types of lipids [149].   
Nanodiscs are pieces of membrane bilayer that are surrounded by membrane scaffold 
proteins [149]. Small sizes of nanodiscs and the presence of lipids around the MP make them 
suitable environment systems for studying MPs; however, the proteins still need to be reconstituted 
in nanodiscs from detergent systems and if the detergents are not chosen carefully the structure of 
the proteins can be affected [149].  
The most recently developed system for stabilization of MPs is the styrene maleic acid lipid 
particles (SMALP) [154]. Addition of styrene maleic acid polymers to the membrane (embedded 
with protein) results in spontaneous formation of disk-like particles (Figure 2-1). SMALP’s 
environment is comparable to nanodiscs but the proteins are directly extracted from biological 
CHAPTER 2 - METHODOLOGIES 
41 
 
membranes without the use of detergents [149, 154]. It has been suggested that the structure of an 
MP in a SMALP particle is very similar to their native structure and SMALP systems are 
considered promising tools for studying MPs.  
2.1.2 Circular Dichroism spectroscopy for structural analysis of membrane proteins 
CD spectroscopy is a robust technique for characterization of the secondary structures of 
proteins, protein folding, and protein interactions [132]. An important strength point of CD is its 
ability to provide information on dynamic structures of the proteins/molecules, which is more 
realistic compared to the data obtained from static molecular structures such as those obtained by 
x-ray crystallography [132]. Differences in the absorption of right- and left-handed circularly 
polarized light by chiral molecules or environments is the cause of production of a CD signal [132]. 
Information about the secondary, tertiary, and quaternary structures of proteins can be derived 
from near- (250-300 nm) and far-UV (190-240 nm) wavelength ranges [132]. The far-UV CD 
signal of a protein is mostly correlated with its backbone secondary structure and is the result of 
π→ π* (at ~190 and ~208 nm), and n→ π* (at ~222 nm) electronic transitions of the amide 
chromophores in the backbone sequence [132]. A protein’s near-UV CD spectrum is usually 
derived from absorbance of aromatic and cystine residues and is sensitive to the microenvironment 
of these chromophores, and therefore provides qualitative information about the protein’s tertiary 
structure [68]. 
The use of CD spectroscopy for structural analysis of MPs is limited compared to that for 
soluble proteins [132]. Peak shifts, absorption flattening, and light scattering are three common 
issues in CD spectroscopy of MPs, which result in uncorrectable and unpredictable distortions in 
the overall shape of CD spectra [132].  
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Red and blue shifts of the peaks are mostly because MPs are always shielded by stabilizing 
environments which are physicochemically different from aqueous solutions of which most of the 
reference databases of CD are generated from [132]. As a result, shifts in positive and negative 
minima of the spectra for MPs can result in large errors in data analysis [132]. In order to minimize 
these types of errors, CD data of MPs should be compared with libraries that include MPs in their 
datasets (such as SMP180 available DichroWeb Server) [132, 155].  
Absorption flattening arises from nonuniform distribution of proteins in solution (since the 
solution is more concentrated inside a vesicle, a bicelle, or a nanodisc), and results in nonlinear 
reduction of the absorbance over the range of wavelengths, and thus could be minimized by 
increasing the homogeneity of the sample or decreasing the concentration of proteins per particle 
[132].  
Light scattering by a particle is a consequence of comparable or larger size of the particles 
in a solution compared to the wavelength of the circularly polarized incident light, which results 
in the production of false signals. Thus, reducing the size of particles to less than the incident light 
wavelength can minimize the adverse effects of light scattering [132]. Since detergent micelles 
usually contain one protein complex per micelle and are smaller in size compared to vesicles, 
bicelles and nanodiscs, absorption flattening and light scattering issues are the lowest for 
detergents [132]; however, as mentioned earlier they cannot fully mimic a bilayer as there are no 
bilayer lipids surrounding the MP [149]. There is always a tradeoff between undesirable artifacts 
of lipidic environments on the CD spectrum and impact of detergent distortions on native 
conformations of MPs [132].    
Some valuable information about the association state of proteins can be intuited by 
analyzing the relative intensity of the minima near 208 and 222 nm in a CD spectrum. It has been 
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experimentally shown that a higher ratio of 208/222 absorbance can indicate a higher probability 
of having a monomeric form and a lower ratio suggests the presence of more associated forms and 
higher density of helix packing [30]. 
2.1.3 Measurement of the rate of proton transport  
In addition to ATP synthesis, translocation of many ions such as K+, Na+ and Ca2+ is 
regulated by the mitochondrial proton gradient across the IMM. [156]. Several techniques have 
been developed for measuring the rate of proton transport by mitochondrial transporters. Methods 
to evaluate the rate of ion transport across the IMM by transporters and channels can be classified 
as direct or indirect as described below.  
One direct system for analyzing proton transport by UCPs involves the use of sensitive pH 
glass electrodes, which are able to detect decreases in pH on the external side of a membrane upon 
activation of reconstituted UCPs (in vesicles) [157]. The patch-clamp method also allows for the 
direct measurement of proton transport [158]. In addition to the ability to measure the number of 
transported ions across a transporter, patch-clamping can provide information about the 
biophysical properties of proteins, such as the number of active subunits within a complex [159]. 
In this method a pipette is pressed against a vesicle or a whole cell membrane in which the MP is 
embedded, to form a “seal”. The application of voltage can imitate the voltage difference across 
biological membranes and result in passage of ions through the channel, the resultant current is 
then amplified and detected [159]. Patch clamp can record currents as low as fractions of a 
picoampere [160]. Patch clamp studies on UCP1 have been used to detect currents of protons in 
mitoplasts and also suggested that UCPs might be oligomeric [161]. 
Indirect methods of measuring proton transport utilize an indicator to probe changes in the 
medium that occur as a result of proton transport. These changes include pH alteration of external 
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or internal media, changes in polarity of the liposome, or formation of anionic species inside the 
liposome upon efflux of protons. For example, pyranine (8-hydroxypyrene-1,3,6-trisulfonic acid, 
trisodium Salt) (HPTS) is a pH-sensitive fluorescent dye that has been used for detection of UCP-
mediated proton transport [63]. The non-fluorescent dye Safranine O is another molecule that has 
been used to detect proton transport [64, 162]. Transport is detected by changes of Safranine O 
optical density (520 nm) upon polarization of liposomes as a result of proton transport by UCPs 
(negative inside, positive outside) [162]. An anion-sensitive fluorescent dye, 6-methoxy- N-(3-
sulfopropyl) quinolinium (SPQ), has also been used for the detection of proton transport by UCPs 
in many studies [133]. Activated UCP is able to transport protons out of liposomes and increase 
the pH of the internal buffer. The anionic species formed due to the increase of pH inside the 
liposome can quench SPQ. Thus, the rate of proton transport can be indirectly measured by the 
rate of quenching of SPQ fluorescence (Figure A-2-1) [133]. To ensure that the calculated results 
are from the proton transport of UCP, and not the basal leakage from the liposomes, a batch of 
blank liposomes (with no protein) should be tested in all methods under the same experimental 
conditions (Figure A-2-1). Additional details about the application of the different methods that 
are available are covered in Chapters 3 and 4 of this thesis. 
2.2 Computational methodologies 
2.2.1 Molecular Dynamic simulations and related techniques 
MD was first introduced as a computational approach to study molecules by Alder and 
Wainwright in the late 1950’s [163, 164]. MD simulations allow particles to interact with one 
another and provide information about the dynamic evolution of the system under study with time 
[165]. This technique helps understand the physical basis of the structure and function of biological 
molecules [165]. The first protein simulations were conducted by McCammon and coworkers in 
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1977 [166]. The MD method has been widely used since then to study the motion of molecules 
and their constituent atoms in biological molecules such as proteins and DNA, and more complex 
systems such as biological membranes [134, 167, 168].  
In MD, the motion of particles is determined by solving Newton’s equations of motion. The 
particles’ potential energies and the forces between the particles are calculated using molecular 
mechanics force fields [169]. A force field is defined by a series of physical equations and 
parameters designed to reproduce selected properties of a system such as geometry or potential 
energy [170]. Each force field includes a separate set of parameters such as bond lengths, angles, 
dihedrals, atomic masses, van der Waals radii, partial charges, and force constants for different 
atom types in different conditions [170]. These parameters are empirical, i.e. extracted from 
experiments or high-level calculations [170]. A force field is able to distinguish a carbon atom 
bound to a hydroxyl group from that in a carbonyl group and assign different values to their 
chemical bond, angle, dihedral, etc. [170].  
Below is a list of popular force fields and the areas in which they are mostly utilized: 
1. AMBER (Assisted Model Building and Energy Refinement): proteins and DNA 
[171]  
2. CHARMM (Chemistry at HARvard Molecular Mechanics): macromolecules and 
small species such as organic ligands [172]  
3. GROMOS (GROningen MOlecular Simulation): biomolecules, isolated molecules 
in gas phase [173]  
4. OPLS (Optimized Potential for Liquid Simulations): macromolecules [174] 
Regardless of the force field type, a typical MD simulation consists of several steps that are 
summarized below and presented in Figure 2-2 [165]. 
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The first step is loading the particle coordinates (coordinates specify the relative position of 
particles with respect to one another; in protein systems, coordinates can be extracted from PDB 
files), force field, and velocities (randomly assigned based on the temperature) as an input of the 
MD simulation [165]. The potential energy of the system and forces imposed on each particle are 
calculated in the next step. The coordinates and velocities are then updated according to the 
equations of motion (Newton’s laws, implemented in the force field) and the output is collected in 
a trajectory file [165]. A trajectory file includes all data related to particles’ motions through space 
as a function of time. Trajectories are then subject to different types of analysis [165].  
 
Figure 2-2 Flow chart representation of a typical MD simulation algorithm. Figure Generated by PowerPoint 
365. 
 
Ideally, the purpose of MD simulation is to explore all possible sets of coordinates (phase 
space) for all atoms of the system; however, in some cases some distinct regions are out of reach 
for a conventional MD simulation technique, e.g., when a potential energy barrier prevents the 
system from reaching particular coordinates [175]. The umbrella sampling technique has been 
developed to enhance sampling of the phase space for such systems, and to overcome and estimate 
the energy barrier (Figure 2-3) [175]. This technique uses a set of new coordinates with larger 
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energies (windows) in comparison to the system’s initial energy. The system is moved from its 
initial coordinate (state) to the neighboring windows in a stepwise manner (Figure 2-3). This 
process continues until the barrier is surpassed [175]. The umbrella sampling method could be 
used to examine the dissociation of proteins, where tremendous interactions among the units 
separate the associated and dissociated forms by imposing a large barrier between the two.  
 
Figure 2-3 Schematic representation of a system for which umbrella sampling could be used. To change the 
state of the system (red circle) from A to B the energy barrier needs to be overcome (green arrow). To achieve this, 
the umbrella sampling technique increases the energy of the system in a stepwise manner until the barrier is passed. 
Each step (window, blue arrow) is a coordinate with a small increase in energy level in comparison to the previous 
one. Figure generated by PowerPoint 365. 
 
Beside the various force fields, several simulation software programs are available to choose 
from based on the expertise of the researcher and the specifications of the system. Some of the 
most popular programs include AMBER [176] CHARMM [177] GROMACS [178], and NAMD 
[179]. Each program follows the steps outlined in Figure 2-2, using the chosen input data (force 
field, input coordinates, velocity/temperature) to run an MD simulation. More details about the 
application of computational methods for studying proteins are provided in Chapters 3 and 4 of 
this thesis. 




CHAPTER 3 - FUNCTIONAL OLIGOMERIC FORMS 
OF UNCOUPLING PROTEIN 2: STRONG EVIDENCE 
FOR ASYMMETRY IN PROTEIN AND LIPID BILAYER 
SYSTEMS 
3.1 Introduction 
UCPs form a subfamily within the MCF superfamily, located in the IMM [60]. UCPs 
attenuate proton motive force by providing a back-flux route for protons to move from the IMS to 
the matrix, resulting in a decrease in the rate of ATP synthesis [180]. Five human UCPs have been 
identified. These proteins transport protons and anions across the IMM and possess comparable, 
dominantly helical, conformations [68]. 
UCP2 is unique among the UCPs in its ubiquitous expression in animal tissues [181]. The 
wide distribution of UCP2 in various tissues suggests that it may play different roles under 
different physiological/pathological conditions [182]. For example, UCP2’s role in decreasing 
mitochondrial ROS concentration has been shown in several studies [183-185]. Moreover, UCP2 
appears to be capable of transporting C4 metabolites [34] and chloride ions [80]. Upregulation and 
anti-apoptotic properties of UCP2 in different cancerous cells have also been proposed [129, 186-
190].  
Comparable to other members of the MCF superfamily, UCPs contain a tripartite structure 
composed of three tandem repeats. Each repeat comprises about 100 amino acids folded into two 
TM α-helices that are connected by a hydrophilic loop positioned toward the matrix side of the 
mitochondrion [70, 180]. Monomeric [83], dimeric [66, 191] and tetrameric [30, 68] structures 
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have been reported as functional forms of UCPs. The monomeric structure of UCP1 has been 
supported by electrophoretic and size exclusion assays and isothermal titration calorimetry 
experiments in decyl maltose neopentyl glycol detergent, which was used (in combination with n-
decyl-β-D-maltopyranoside) for the purification of the protein [83]. Lee et al. also reported that 
monomeric UCP1 was the only functional form of the protein; however, they were not able to 
convincingly justify the appearance of higher molecular masses in their assays [83]. Dimeric UCP1 
structure has been a more traditional view based on cross linking [66], ultracentrifuge [65], and 
nucleotide binding studies [192]. Tetrameric form of UCP1 has been reported for recombinantly 
expressed proteins in bacterial membranes (not as inclusion bodies); and the possibility of co-
existence of monomeric, dimeric and tetrameric UCPs as functional forms of the protein(s) was 
suggested [68]. Based on the analysis of mitochondrial Ca2+ uptake, Trenker et al. suggested that 
UCPs co-assemble to form homo- (UCP2+UCP2) or hetero-multimers (UCP2+UCP3) [42]. 
Moreover, assembly of UCPs with other MCFs, such as AAC proteins, has been reported [122]. 
Overall, the absence of a widely accepted high resolution structure for UCPs [64], variations in 
recombinant expression methodologies, and limitations accompanied by the choice and 
optimization of detergents for protein reconstitution in membranes are among the common 
shortcomings of all in vitro studies [59, 68].   
Permanent and transient homo-oligomerization has been observed in many MPs [193]; 
among all enzymes listed in the Brenda enzyme database (https://www.brenda-enzymes.org), only 
31.2% function as monomers and the rest (68.8%) are known to be oligomers [194]. Self-assembly 
of proteins is not limited to soluble proteins. In fact, co-assembly of integral MPs to functional 
oligomers has been reported for several systems [195-199]; proteins such as aquaporins and 
aquaglyceroporins (six membrane-spanning α-helices per subunit similar to UCPs) [195, 196], as 
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well as several potassium channels from bacterial, archaeal or eukaryotic sources [197, 198], can 
all form homo-tetrameric structures within the bilayer. Many homo- and hetero-tetrameric proteins 
are, in fact, functional in the form of dimer of dimers (containing two different molecular 
interfaces; one between the monomers within the dimeric unit and another between the dimers). 
Examples include streptavidin, transthyretin, hemoglobin [200] and GlpF [199]. 
Association of MPs is sometimes mediated and/or regulated by lipids, and delipidation by 
detergents can dissociate the multimeric proteins to monomers [114, 193]. It has been shown that 
lipids, such as CL, can also act as specific ligands to assist multimerization by bridging between 
monomers [36]. The lipid membrane therefore not only acts as a solvent medium for MPs, but also 
plays a crucial role in MPs’ function, organization and assembly [201]. Reconstitution of proteins 
into lipid membrane models (e.g. liposomes) is an essential tool in MP research [202-204]. Lipid 
constituents of liposomes can assist the self-association of subunits of oligomeric proteins within 
the bilayer (also addressed as the chaperoning effect) [197, 204]. For reviews of lipid-protein 
interactions, see refs. [205] and [206]. 
In order to address the first goal of the thesis (analyse the functional structure of UCP2 in 
the membrane) , recombinantly produced UCP2 was reconstituted into vesicles composed of egg 
yolk lipid extract, which mainly contains PC and PE, the most abundant lipids in mitochondrial 
membranes [130]. Self-association of UCP2 was also investigated in the absence and presence of 
cardiolipin to evaluate the impact of lipid composition and specific lipid interactions on 
oligomerization of UCP2. UCP2 conformation, self-association and proton transport were 
investigated by CD spectroscopy, gel electrophoresis, western blotting and fluorescence ion 
transport assays. Moreover, conformation and self-association behavior of UCP2 in lipid 
membranes was compared to those of the structurally analogous bovine mitochondrial AAC1, 
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(PDB ID: 1OKC), under similar experimental conditions [60, 70, 207]. To further investigate the 
self-association of UCP2 in lipid membranes, atomistic MD simulations were performed. 
3.2 Material and methods 
3.2.1 Chemicals 
L-α-Phosphatidylcholine type X-E (L-α-PC) was from Sigma-Aldrich (St. Louis, Missouri). 
This mixed lipid system was extracted from dry egg yolk and contained more than 60% (by weight) 
PC; the remaining lipids were mostly phosphatidylethanolamine and other phospholipids. C8E4 
was from Bachem (Bubendorf, Switzerland). OG was obtained from BioVision (San Francisco, 
California). SPQ was from Biotium (Fremont, California). Other chemicals were from Sigma-
Aldrich. 
3.2.2 Overexpression and membrane extraction of proteins 
The cDNAs encoding UCP2 and AAC were cloned into the pET26b(+) expression vector 
[68], and recombinant versions of UCP2 and AAC1 (UniProt Accession Codes UCP2 – P55851 
and AAC1 – P02722, with poly-histidine affinity tags at their N-terminal) were expressed in E. 
coli BL21 (DE3)-RIL (codon plus) and BL21 (DE3) cells using the auto-induction method as 
previously described [68, 208]. Briefly, the bacterial cells were incubated for 22 hours in the auto-
induction media [0.5% yeast extract, 0.5% glycerol, 1% tryptone, 0.2% lactose, 0.05% glucose, 50 
mM KH2PO4, 50mM Na2HPO4, 1mM MgSO4, 25 mM (NH4)2SO4] at 22 °C.  After 22 hours, the 
culture was centrifuged at 8000 g for 15 minutes and the bacterial cells were collected in the pellet. 
The pellets were resuspended in lysis buffer [500 mM NaCl, 20 mM Tris-HCl pH 8.0, one EDTA-
free complete protease inhibitor tablet (Roche, Basel, Switzerland), 0.5 mg/ml DNase and 0.2 
mg/ml lysozyme]. A high-pressure cell disruptor (Constant Systems Limited, Daventry, UK) was 
used to lyse the cells (at 20 kPsi). The lysate was centrifuged for 20 minutes at 20000 g to remove 
CHAPTER 3 - FUNCTIONAL OLIGOMERIC FORMS OF UNCOUPLING PROTEIN 2 
52 
 
intact cells or aggregated proteins. The supernatant was collected and ultracentrifuged at 50000 g 
(MLA 80 rotor, Beckman Coulter) for 1 hour to obtain the bacterial membranes in the pellet. 
NADH oxidase activity assay was used to confirm that the fraction was enriched in bacterial 
membranes [68]. In this assay the membrane-embedded enzyme NADH catalytic activity is 
assessed based on its ability to convert NADH from its reduced to oxidized forms, as explained 
previously [68]. 
3.2.3 Purification of proteins using immobilized metal affinity chromatography 
Binding buffer containing 20 mM Tris-HCl, 1 mM THP [Tris (hydroxypropyl) phosphine], 
500 mM NaCl, 1% LDAO detergent and 10 mM imidazole was used to solubilize the bacterial 
membrane. The solution was then incubated with nickel-nitrilotriacetic acid (Ni-NTA, Thermo 
Scientific Waltham, Massachusetts) resin for 2 hours and subsequently transferred to a column. 
Detergent exchange (from 1% LDAO to 1% OG) was performed on the column at the washing 
step.  In the case of UCP2 the resin in the column was washed with buffer containing 12 mM 
imidazole and successively eluted with buffers containing 25, 40 and 400 mM of imidazole in 1% 
OG detergent. The mixture of monomers and associated molecular forms of proteins were eluted 
at 40 mM imidazole and the pure monomer was eluted at 25 mM of imidazole. For AAC1, the 
column was washed with 30 mM imidazole and eluted with 400 mM imidazole in 1% OG 
detergent. Econo-Pac 10DG Columns (Bio-Rad, Hercules, California) were used to desalt the 
fractions in desalting buffer (20 mM Tris-HCl, 1% OG, 1% glycerol, pH 8.0). Purity and 
concentration of proteins were analyzed with semi-native PAGE (polyacrylamide gel 
electrophoresis) and modified Lowry assay [209], respectively. The desalted proteins were stored 
in desalting buffer at –80 °C. 
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3.2.4 Semi-native PAGE analysis 
To analyze proteins using semi-native PAGE [68], SDS was excluded from the sample 
buffer, and its concentration was considerably reduced in the gel and running buffer as compared 
to SDS-PAGE conditions ([SDS] in the running buffer = 2 mM in semi-native vs. 35 mM in 
denaturing conditions). Moreover, samples were not heated before loading on the gel. The gels 
were run at 120 volts, stained with 0.2% w/v solution of Coomassie Brilliant Blue R-250 in acetic 
acid, methanol and water (10:45:45 by volume) for 2 hours and destained overnight.  
3.2.5 Western blot analysis 
The identity of overexpressed recombinant wild-type UCP2 and AAC1 were confirmed by 
immunoblotting. Proteins (5-10 μg) were loaded on semi-native PAGE gels, and using the semi-
dry technique, the proteins were transferred (75 minutes -110 volts) to nitrocellulose. The filters 
were stained with Amido Black to confirm transfer efficiency [210]. The nitrocellulose filters were 
blocked for at least 60 minutes in Tris buffered saline containing 0.1% tween-20 and 5% dry skim 
milk. The primary antibody used to detect UCP2 was 1:2000 dilution of anti-UCP1/2/3 raised in 
rabbit (Santa Cruz Biotechnology Inc. Dallas, Texas), and for AAC1 the primary antibody was 
1:5000 dilution of rabbit IgG anti-AAC1 (Bio-Rad). The secondary antibody was 1:5000 dilution 
of horseradish peroxidase (HRP) conjugated antibody raised in a goat against rabbit IgG 
(Rockland, Limerick, Pennsylvania). Luminata Crescendo Western HRP substrate (Millipore 
Sigma) was used as a chemiluminescent reagent to achieve immunodetection. A Bio-Rad 
VersaDoc imaging system was employed to capture the images.  
3.2.6 Reconstitution in lipid vesicles 
Reconstitution of UCP2 and AAC1 into lipid vesicles followed a previously described 
procedure [30, 80], with minor modifications. Briefly, solutions of egg yolk PC in MeOH: 
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chloroform (1:3) were dried for 8–12 hours under vacuum. The dried lipids were solubilized in an 
appropriate reconstitution buffer (supplemented with 3 mM SPQ fluorescent probe in proton 
transport assays) to generate multilamellar vesicles which were consequently solubilized in C8E4 
detergent to form lipid-detergent mixed micelles [at a lipid/detergent ratio of 1/2.5 (w/w)]. Pure 
proteins were added to the mixed micelles to reach the final 3 μM concentration. Protein/lipid ratio 
was ~1/6000 (mol/mol) for proton transport assays and ~1/600 (mol/mol) for CD experiments. 
Unilamellar proteoliposomes were spontaneously generated by removing the detergent using SM-
2 Biobeads (Bio-Rad). The average radii of the prepared proteoliposomes for the proton transport 
assays and CD measurements were 76.87±2.29 nm and 31.46±1.68 nm, respectively, as 
determined by dynamic light scattering. On average, the radii of the blank liposomes were ~13% 
larger than the proteoliposomes in both cases. In proton transport assays, part of the added SPQ 
was entrapped inside the liposomes and the external SPQ was removed by size-exclusion 
chromatography, using a Sephadex G25-300 (GE-Healthcare, Chicago, Illinois) spin column. 
Blank (protein-free) liposomes were prepared simultaneously in parallel with proteoliposomes. 
3.2.7 CD spectroscopy and fluorescence measurements  
Far-UV CD measurements were performed at 25 °C, at 1 nm resolution, on an AVIV 215 
spectropolarimeter (Aviv Biomedical, Lakewood, New Jersey). Quartz cells with 0.1 cm path 
length were used for measuring the CD spectra in OG detergent and in liposomes. Ellipticities 
were converted to mean residue ellipticity, [θ]. Each spectrum was an average of 6–12 
measurements. 
Steady-state fluorescence measurements of the liposomes were performed using a Cary 
Eclipse spectrophotometer (Varian, Palo Alto, California) with a band width slit of 5 nm and a 
scan speed of 600 nm/min. Excitation and emission of the SPQ fluorescence signal were at 347 
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and 442 nm, respectively. The fluorescence scans were performed at 25 °C.  Each proton transport 
analysis was an average of 10 independent measurements. 
3.2.8 Proton transport measurements 
Proton transport rates were measured following reconstitution in lipid vesicles, as described 
previously [80]. Anions quench SPQ by a dynamic collision mechanism. In proton transport 
assays, 40 μL of liposomes were mixed with 1.96 mL of external buffer. The internal buffer was 
composed of TEA2SO4 (TEA: tetraethylammonium, 54 mM), TES buffer (20 mM) and EDTA 
(0.7 mM). The external buffer had a similar composition to the internal buffer, with TEA2SO4 
replaced by K2SO4 (54 mM). The pH of both buffers was kept constant at 7.2. Palmitic acid (as 
palmitate) [PA, [PA]=100 μM] was used to activate the UCP2-mediated proton flux. The addition 
of valinomycin mediated the influx of K+ which triggered fatty acid dependent proton efflux of 
UCP2. Proton efflux by UCP2 resulted in deprotonation of the TES buffer. TES– anions quenched 
the SPQ emission. The rate of decrease in the SPQ fluorescence signal was correlated to the rate 
of fatty acid activated proton transport of UCP2. The latter was measured by monitoring the 
decrease in SPQ’s fluorescence signal intensity within the first 30 seconds after addition of 
valinomycin [68]. All proton transport data in liposomes were corrected for the basal non-specific 
leakage by subtraction of blank liposomes proton efflux. Furthermore, the proton transport data 
were calibrated for internal volume, SPQ’s fluorescence response and protein concentration. The 
concentration of protein in proteoliposomes was calculated using a modified Lowry assay [80, 
209], No significant proton transport/leakage has been observed for the proteoliposomes in the 
absence of valinomycin. The inhibitory role of ATP on proton transport rates of reconstituted 
UCP2 was assessed by incubating the proteoliposomes with 500 μM ATP for 2 minutes prior for 
measurements. 
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3.2.9 MD simulations 
The NMR structure of UCP2 (PDB ID: 2LCK) [70] was used as the starting structure for the 
monomeric UCP2. The same structure was used to build the dimeric and tetrameric forms. To form 
multimeric UCP2, the monomer units were aligned in such a way that the GXXXG [127], 
GXXXAXXG [211], and SmXXXSm (Sm = Gly, Ala, Ser, Thr) [124, 212] motifs were involved in 
the interactions with the neighboring unit(s) (Figure A-3-1); these motifs have been proposed to 
promote helix-helix interaction.48 Moreover, in the case of dimer, several relative orientations for 
the monomers were examined. From these, the parallel orientation with maximal (distance-based) 
favorable interactions (electrostatic and hydrophobic) was chosen for the simulations. The tetramer 
was then built analogously from two dimers. The X-ray structure (PDB ID: 1OKC) was adopted 
as the initial AAC1 structure.  
The protein-membrane systems were built using CHARMM-GUI [213] Membranes were 
built with 300, 316, and 498 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) lipids for the 
monomeric, dimeric, and tetrameric UCP2, respectively. In the case of AAC1, 160 and 200 POPC 
lipids were used for monomeric and dimeric forms, respectively. POPC was chosen to model the 
membranes, since PC is the main constituent of IMM [131, 214]. 
Each system was solvated in an explicit TIP3P water [215] box (total of 24195, 28463, and 
47881 water molecules for monomer, dimer, and tetramer, respectively. For AAC1 systems the 
numbers are 9806 and 13555) and 0.15 M KCl (65, 78, and 134 K+, and 80, 108, and 194 Cl– for 
the monomer, dimer, and tetramer, respectively. For AAC1, 25 and 36 K+, and 42 and 70 Cl– for 
the monomer and dimer, respectively). Overall charge neutrality was always maintained. 
CHARMM36m/CHARMM36 protein/lipid force fields were used [216, 217]. All systems were 
first energy minimized using the steepest descents algorithm followed by 500 ps of pre-
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equilibration under constant volume and temperature (NVT), and constant pressure and 
temperature (NPT) conditions. MD simulations were conducted for 350 ns with 2 ps time steps 
using GROMACS/2018 [218]. Chemical bonds were constrained using the linear constraint solver 
(P-LINCS) algorithm [219]. The Nosé-Hoover thermostat [220, 221] was employed to maintain 
the temperature at 300 K with a 1.0 ps coupling constant and the Parrinello–Rahman barostat [222] 
with a compressibility of 4.5 × 10−5 bar−1 and a 5 ps coupling constant was used. The particle mesh 
Ewald method [223, 224] was used for the long-range interactions. The above protocol and 
methods have been shown to be reliable in a number of previous studies (e.g., Refs. [225-227] and 
references therein). 
We tested the force field dependence by studying the protein structure in POPC bilayers 
employing CHARMM36m, CHARMM36 and CHARMM27 force fields neutralized by either Cl– 
ions or KCl salt in the absence and presence of GDP3–. MD simulations were carried out for 100 
ns for a total of 12 additional individual systems. The robustness of the results was further 
examined by additional simulations using different initial conditions.  
To study the dissociation process of the multimers, umbrella sampling [228] was conducted 
on the final structures obtained from the 150 ns MD simulations. Selected windows of 0.1 nm 
along the pulling trajectories were first equilibrated for 100 ps and production runs were carried 
out for 5 ns. Theses trajectories are short since the aim was not to determine the absolute free 
energy curve, but rather to have an estimate for the binding energies. Protein subunits were pulled 
from their centers of masses until the subunits were separated by at least one layer of POPC. The 
weighted histogram analysis method (WHAM) was used for the analysis [229]. Potential of mean 
force was monitored to confirm the end of the process. The bootstrap technique was used to 
estimate the statistical errors [230]. 
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3.3 Results  
3.3.1 Expression and purification of UCP2 and AAC1 
Cloning the cDNAs of UCP2 and AAC1 into pET26b(+) resulted in the pelB signal peptide 
being added to the N-termini of the proteins, which targets the proteins to the E. coli inner 
membrane [68], followed by His-tag. The pelB signal peptide normally directs secreted proteins 
to the periplasmic space. The TM segments of UCP2 and AAC1, however, prevent full 
translocation and lead to insertion into the membrane due to hydrophobic interactions with the 
bacterial membrane [30, 68]. Expression of proteins in bacterial membranes allows the protein and 
its surrounding tightly attached membrane lipids to be extracted with mild detergents and co-
purified with protein. These co-purified membrane lipids can shield the protein from potential 
denaturing interactions with the solubilizing detergent, and thus help UCP2 to remain relatively 
intact/folded. The His-tagged proteins were purified on nickel-containing columns. Purity was 
confirmed by semi-native PAGE (Figure 3-1). Bands of approximately 33, 66 and 132 kDa were 
observed for UCP2 on polyacrylamide semi-native gels. Furthermore, Western blot analysis using 
an α-UCP1,2,3 antibody reacted with all three bands (Figure 3-1), suggesting that they correlate 
as monomeric, dimeric and tetrameric forms of UCP2, respectively - as has been observed 
previously [30, 68]. Under similar conditions, only monomeric and dimeric forms were detected 
for AAC1 (Figures 3-1 and A-3-2).  
3.3.2 Semi-native PAGE analysis of UCP2 and AAC1 before and after reconstitution 
As shown in Figure 3-1, UCP2 existed as a mix of monomeric, dimeric and tetrameric forms 
when purified in the presence of OG detergent. OG was chosen on the basis of conformational and 
thermal stability analysis of UCP1 in different detergents [such as OG, DDM (n-dodecyl-β-D-
maltopyranoside) and LDAO] [68]. Overall structural integrity of the protein was most stable when 
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purified and stored in OG micelles [68]. Once reconstituted in lipid vesicles from detergents, the 
electrophoretic analysis showed that only tetrameric forms of UCP2 are present in liposomes (lanes 
3 and 5 in Figure 3-1). Interestingly, the electrophoretic analysis showed that regardless of the 
lipid composition and presence/absence of cardiolipin, only tetrameric forms of the reconstituted 
UCP2 are present in liposomes. 
 
Figure 3-1 Semi-native PAGE analysis of purified UCP2 and AAC1 in OG detergent (D) and in liposome (L) 
detected by Coomassie blue staining (lanes 2-7) and Western blot (W) (lane 1) methods. Mixture and monomer 
terms displayed at the top refer to the protein sample that was used for reconstitution. The solid arrows show the 
locations of oligomers and the open arrow shows the monomers. Western blot detection of UCP2 in OG detergent 
was probed with an α-UCP 1, 2, 3 antibody. Collectively, the data confirm the presence of tetrameric UCP2 and 
the absence of tetrameric AAC1 in lipid vesicles. The protein/lipid molar ratio in lanes 3 and 5 was 1/6000. 
 
To further investigate the spontaneous oligomerization of UCP2 in lipid membranes, the 
protein was isolated from E. coli membranes in its monomeric form in the OG detergent and 
reconstituted in liposomes. The electrophoretic analysis results show that reconstituted UCP2 
monomers also spontaneously self-associate into tetramers (lanes 4 and 5 in Figure 3-1). To test 
the reliability of the reconstitution process and the possibility of tetramerization of other MCF 
proteins, a purified mix of AAC1 monomers and dimers were reconstituted into liposomes under 
comparable experimental conditions. The carrier protein AAC1, with structural similarities to 
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UCP2, did not form tetrameric complexes in lipids; instead, it maintained its original mix of 
monomeric and dimeric forms (lanes 6 and 7 in Figure 3-1).  
Other evidence for spontaneous self-association of UCP2 into homo-tetramers in liposomes 
comes from its proton transport function (Figure 3-2). Both reconstituted forms of UCP2 resulted 
in similar ion transport profiles (Figure 3-2, right). This observation confirms the functional 
equivalence of reconstituted proteins from different preparations (monomeric vs. mixed 
monomeric/multimeric). The proton transport rates of tetrameric UCP2 from reconstituted 
monomeric and mixed species in liposomes were comparable: 5.16±0.03 and 5.24±0.09 
μmol/min/mg of protein, respectively.  
 
Figure 3-2 Formation of functional UCP2 tetramer after reconstitution in vesicles. Regardless of its molecular 
composition in detergent (monomeric or mixed monomeric/multimeric, before reconstitution), UCP2 adopts a 
tetrameric form in lipid vesicles. The bar graph on the right, shows the comparable rate of proton efflux for UCP2 
in proteoliposomes generated either from monomeric or mixed molecular species. Each bar represents the average 
transport rate of 10 repeats and the error bars show the standard deviations. Figure generated by ChemBioDraw 
Ultra 14.0 
 
The proton transport function of the tetrameric proteins was further examined in the presence 
of a common inhibitor (ATP, 500 μM). Results showed that, in both cases, the rate of proton 
CHAPTER 3 - FUNCTIONAL OLIGOMERIC FORMS OF UNCOUPLING PROTEIN 2 
61 
 
transport was ~80% less compared to that of uninhibited proteins (1.03±0.02 and 1.17±0.09 for 
UCP2 tetramers from reconstituted monomeric and mixed proteins, respectively). These results 
also exclude the possibility of non-specific proteoliposome leakage. The observed proton transport 
and inhibition rates are comparable with previous independent studies [30, 71, 231].  
3.3.3 CD spectroscopic conformational analyses of UCP2 and AAC1 
Conformations of UCP2 and AAC1 in OG and liposomes were characterized and compared 
by CD spectroscopy (Figure 3-3). The CD spectra of both proteins exhibited helical backbone 
structures with a characteristic double negative maxima at 208 nm and 222 nm, as well as a positive 
maximum around 193 nm (not shown), corresponding to π → π* (193 and 208 nm) and n → π* 
(222 nm) transitions of the peptide bond [232].  
In UCP2, the far-UV CD signal was notably enhanced after reconstitution in liposomes, 
indicating a higher helicity compared to that of protein in OG detergent (Figure 3-3, A). This 
marked conformational change, reflected as enhancement of negative ellipticity and reversal of the 
relative intensity of minima (θ208/θ222), reveals the essential role of the lipid environment in folding 
and structural stabilization of UCP2. In addition to their difference in signal intensity, the shape of 
the CD spectrum of UCP2 in proteoliposomes differed from that of the monomer (and the mixed 
monomer/multimer) in OG. Particularly, in lipid vesicles, a shoulder-like π → π* parallel transition 
band around 208 nm replaced the minimum band in OG, and also a considerably more intense n 
→ π* transition band appeared at 222 nm. The θ208/θ222 ellipticity ratio of UCP2 monomer 
spectrum changed from 1.07 to 0.68 after reconstitution in liposomes (Figure 3-3, A). The θ208/θ222 
ellipticity ratios lower than one has been previously reported for human UCPs’ helical bundle 
motifs and their self-associated oligomers [30]. Relative decrease in molar ellipticity at 208 nm (in 
comparison to ellipticity at 222 nm) and its red shift, due to intramolecular interactions between 
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TM helical motifs and intermolecular protein association, have also been reported for UCP1 and 
other MPs [68, 233-235]. The CD spectra (Figure 3-3, A) related to the tetrameric form of UCP2 
is in good agreement with our previously reported studies [30, 68]. CD spectra of the mixed 
molecular forms of UCP2 (monomer, dimer and tetramer) and AAC1 (monomer and dimer) in OG 
detergent exhibited comparable helical conformations (Figure 3-3, B), as expected based on the 
known structural similarities and co-presence of different monomeric and associated molecular 
forms in these proteins.  
 
Figure 3-3 CD spectra of purified UCP2 and AAC1 before (in OG detergent) and after reconstitution in 
liposomes at 25 °C. A) Tetramer formation of UCP2 in liposomes, regardless of its original molecular composition 
in detergent, resulted in a drastic change in CD spectrum. B) Comparable CD spectra of AAC1 before and after 
reconstitution implies a comparable molecular composition of the protein in liposome vs. detergent. Concentrations 
of proteins were 5 – 8 μM in OG and ~ 1 μM in lipid vesicles. Each spectrum is an average of 6-12 measurements.   
 
Compared with UCP2, the negative ellipticity for AAC1 in liposomes was less enhanced 
(Figure 3-3, B). The θ208/θ222 ellipticity ratio of AAC1 changed from 0.89 in OG detergent to 0.84 
after reconstitution in liposomes, which is consistent with the protein maintaining similar 
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conformations in these environments (mix of monomeric and dimeric forms) (Figure 3-3, B). The 
differences between the CD spectra of reconstituted UCP2 and AAC1 show that the two proteins 
acquire different molecular forms after reconstitution in vesicles. In liposomes, both the lower 
negative ellipticity and higher θ208/θ222 ellipticity ratio of AAC1 compared to UCP2 (0.84 vs. 0.68) 
are consistent with a lower degree of association in AAC1. In summary, our experimental results 
show that UCP2 and AAC1 behaved differently in liposomes. UCP2 associated into a functional 
tetramer, while AAC1 did not form tetramers in liposomes. 
3.3.4 MD simulations 
3.3.4.1 Protein Properties 
It is well established that interactions of TM helices within lipid bilayers have crucial roles 
in folding [236], stability [237-239], and function [240] of MPs. All-atom MD simulations were 
conducted on monomeric, dimeric and tetrameric UCP2 in POPC model bilayers, and monomeric 
and dimeric AAC1. PC is one of the main constituents of the mammalian IMM (~40%) [130, 214]. 
CL is another important component of IMM (~18%); however, our experimental results indicated 
that the presence or absence of cardiolipin in the membrane did not affect the oligomerization of 
UCP2, Accordingly, and in order to keep the systems simple and comparable to other studies  
[241], we did not include this lipid in our model bilayers. Average root-mean-square-deviations 
(RMSDs), radius of gyration (Rg), principal component analysis (PCA), solvent accessible surface 
area per chain (SASA), and pore radius and free radius were determined. Moreover, umbrella 
sampling simulations were carried out to examine the stability of the multimeric forms of UCP2 
and to provide further insights into the protein’s subunit interactions and oligomerization process. 
The general structural features of the protein were always preserved in all three UCP2 
systems through intensive interactions with the phospholipid bilayer. This was the case 
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independent of the force field and reproducible in repeated simulations with different initial 
conditions. Figure 3-4 compares the initial and final (350 ns) structures of monomeric UCP2 and 
shows the final arrangement of the dimeric and tetrameric forms. RMSD is a measure of flexibility 
of the structure and indicates the deviation of atomic positions from the initial structure. RMSD of 
the protein backbone over the course of simulations (Figure A-3-3) indicates that in POPC bilayers, 
all three forms had reached a steady-state or equilibrium and were stable. The tetrameric UCP2 
showed the smallest fluctuations in RMSD, suggesting it to be more stable than the other two 
forms.  AAC1 structures are provided in Figure A-3-4 and as suggested by the backbone RMSD, 
both monomeric and dimeric forms remained stable in the phospholipid bilayer (Figure A-3-3). 
Figure 3-4 shows that over the simulation time, both dimeric and tetrameric UCP2 adopted 
asymmetric conformations, that is, the deviations from the initial structure were not similar among 
their constituting subunits. The differences between the monomeric and oligomeric forms of the 
protein arise from the changes in the local environment of the monomeric UCP2 upon association, 
altering the modes of protein-environment interactions and protein motions in the lipid bilayer. 
The effect of environment on protein motion was further explored with PCA of the proteins (Figure 
A-3-5 and A-3-6). PCA analyses indicated greater motions in the TM helices for the multimeric 
UCP2 in comparison to the monomeric protein during the simulation. As seen in Figure A-3-6, 
certain parts of the subunits of dimer and tetramer moved in different manners resulting in an 
overall contraction of the protein. This contraction was especially observable in the tetramer. It is 
likely to arise from its structure as a dimer of dimers as will be discussed below in connection with 
salt-bridges. Rg is a measure of compactness of the structure and SASA is the surface area of the 
protein that is exposed to the solvent. While Rg remains relatively similar for the two AAC1 forms, 
SASA for the dimeric form decreases compared to that of the monomeric AAC1. 
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In agreement with a previous MD study of monomeric UCP2 [64], the SASA of all three 
molecular forms of UCP2 (Figure A-3-3) were reduced in the lipid bilayer compared to the initial 
structure (monomeric) in detergent micelles. Variation of protein SASA in different environments 
is common and has been reported for a number of proteins [242-244]. As seen in Figure A-3-3, 
the SASA of UCP2 monomer and dimer are very similar and the changes are only considerable 
upon dimerization of UCP2 dimers (tetramerization of subunits). SASA of the tetramer was not 
only the smallest among the considered UCP2 forms, but also closely resembles that of AAC1 
with widely accepted structure and transport features (discussed later).  
The loops on both matrix and cytoplasmic sides of the protein were able to move more freely 
throughout the simulation and might form transient hydrogen bonds with one another and solvent, 
keeping the multimeric structures intact and protecting the transport controller gates on matrix or 
intermembrane side of the protein. These gates are salt-bridge networks that are proposed to 
regulate the transport in MCF carriers with consecutive opening and closures [51]. 
Dimeric and tetrameric UCP2 were subjected to umbrella sampling simulations to evaluate 
the energy of dissociation of the dimer to monomers, and the tetramer to dimers (Table A-3-1 and 
Figure A-3-7). Smaller dissociation energy of the tetramer into two dimers (60.2 kcal/mol) 
compared to the dissociation energy of the dimer (78.7 kcal/mol) is consistent with our previous 
experimental reports on UCP [30, 68], which suggests that the tetrameric complex of UCPs is in 
fact a dimer of dimers (see Discussion section).  
In the UCP2 dimer, stabilizing salt-bridges between the monomeric subunits (chains 1 and 
2) of the dimer (K109∙∙∙D202, E112∙∙∙K206 and K164∙∙∙E46) were observed. Interestingly, in the 
tetramer contacts between chains 1 and 2 (K109∙∙∙D202 and K164∙∙∙E264) and chains 3 and 4 
(K104∙∙∙D202 and K164∙∙∙E264) within the tetramer were present (Table A-3-1 and Figure A-3-8). 
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Importantly, no salt-bridges were formed between the two dimers. This is also consistent with 
UCP2 tetramer being a dimer of dimers. 
 
Figure 3-4 Overlay of the UCP2 monomer (A-C) initial (PDB ID: 2LCK, yellow) and final (350 ns, green) 
structures. (D) final dimer and (E) tetramer structures. An overall shrinkage is observed upon insertion of the 
protein into the POPC bilayer. The monomeric subunits within the dimeric and tetrameric structures are not 
identical, leading to asymmetric protein oligomers. Figure generated by VMD 1.9.3. 
 
UCPs are transporters and the existence of pores across the individual monomers were 
determined using MoleOnline software [245]. The results were also compared to those calculated 
with CAVER [246] and found to be consistent. Two different pore radii were determined, 1) the 
free radius that uses the closest three protein backbone atoms and 2) simple radius which uses all 
the atoms of an instantaneous configuration. The free radius is a more realistic measure and was 
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used in data analysis. Comparison between the initial and final free radii of UCP2 structures in 
Figure 3-5, A shows that in the monomeric form it shrinks on the matrix side. The free radii of the 
dimer’s subunits do not change significantly and are comparable to that of the initial monomer. In 
the tetramer, free radii of two of the subunits markedly reduce on the matrix side, while the other 
two have smaller free radii on the cytoplasmic side. Free radius analysis of AAC1 indicates a large 
change on the matrix side for both monomeric and dimeric forms compared to the initial structure, 
Figure 3-5, B.  
 
Figure 3-5 Protein pore free radius for initial and final structures of UCP2 (A) and AAC1 (B). For all UCP2 
and AAC1 forms the free radius changes quite drastically from its initial structure. Distance of zero is on the matrix 
side. Free radius is measured by fitting spheres within the channel limited by the three closest main chain atoms. 
 
We compared our free radii of the monomeric forms to the effective radii reported by 
Zoonens et al. [64] While they only report UCP2-GDP3- system shrinking on the cytoplasmic side 
in a POPC bilayer, our simulation shows a contraction on the matrix side (distance = 0 nm in 
Figure 3-5) for UCP2 in absence of the inhibitor (Figure 3-5). Moreover, in the case of AAC1, the 
pore radius opens up on the matrix side over the simulation and becomes slightly larger than the 
radius on the cytoplasmic side (Figure 3-5).  
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3.3.4.2 Membrane Properties 
To evaluate the effects of the protein oligomerization on the membrane, several bilayer 
properties such as area per lipid (APL), APL distributions and lipid distribution s were examined. 
APL is a measure of membrane compactness. Higher density leads to a lower APL and thicker 
membranes. Figure 3-6, A shows the APL distribution and the average APL for the monomeric 
UCP2 system. As the figure shows, APL is smaller for the upper leaflet. The situation, however, 
reverses for both oligomeric forms (Figures 3-6, B-C). This data shows how multimerization of 
UCP2 has marked impacts on bilayer properties.  
Figure 3-7 represents 2D averaged (over the last 50 ns) APL distribution in the two leaflets. 
The contours can be considered as the protein’s lipid “fingerprint” [247], i.e., how the protein 
affects the packing of its neighboring lipids. While originally the fingerprint idea was used to 
determine what kind of a local lipid environment (in terms of lipid species) a protein recruits, here 
we have a single lipid species and use the fingerprint to characterize the local modulations the 
protein causes. The area with the deep blue color in the middle is where the protein(s) is (are) 
located. The plots show a strong asymmetry between the leaflets in all cases. Close to the protein, 
the deep red color and larger APL appears to indicate that lipids at the interface are very fluidic 
(since volume of a bilayer is usually considered to be roughly a constant). That, however, is not 
the case here. Instead, the interfacial lipids have very low mobility due to the strong interactions 
with the protein and their tails become distorted. This is what leads to the observed higher APL.  
This is also reflected in local membrane height distribution along the z-axis, Figure 3-8. The 
areas of lower thickness correspond to larger APL close to the protein. As Figure 3-8 shows, the 
distribution is different for the two leaflets and the different protein oligomeric states. The 
distribution for the lower leaflet (matrix side) obtains a fat tail toward the membrane interior 
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(smaller thickness) and the average lipid z-position (shown with dashed lines) changes upon 
oligomerization. In the case of the tetramer, there is also a small but clear contribution from the 
membrane interior (i.e., few phospholipids that penetrated deeper, indicated by the arrow in Figure 
3-8A). It was also observed that a few lipids insert their headgroup partially in one of the cavities 
on the tetramers’ side. Upper leaflet (cytoplasmic side) lipid distributions of the monomeric and 
dimeric UCP2 systems are practically indistinguishable and have overlapping averages (the blue 
dashed line is behind the orange one). For the tetramer, the distribution curve becomes 
significantly broader and the average lipid position changes. The two leaflets show opposite 
behaviors: On the matrix side the z-positions move toward smaller values (center) and on the 
cytosol side toward larger (away from the center). Thus, tetramerization causes a relatively large 
impact on both leaflets with skewed distributions.  
In the case of AAC1, there is only a negligible change in the lipid distribution on the matrix 
side upon dimerization (Figure A-3-9), while on the cytoplasmic side (upper leaflet) the average 
lipid position has moved toward the bilayer center. Overall, dimerization of AAC1 has only a small 
impact on the average lipid position on both leaflets.  
3.4 Discussion  
Several functions, including proton motive force attenuation and ROS regulation, have been 
proposed for UCP2 [183-185]. On the other hand, the only published atomic structure of any UCP 
is that of UCP2, using a semi-empirical fragment searching NMR analysis [70]. The functional 
molecular form of UCPs (in particular UCP1) in mitochondria has been a subject of debate, with 
some researchers proposing monomers [67] and others proposing oligomers as possible functional  
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forms [30, 66, 68], Molecular characterization of the functional structure(s) of UCPs is essential 
for understanding their mechanisms of physiological action.  
 
Figure 3-6 The APL distribution in upper and lower leaflets in the cases of (A) monomeric, (B) dimeric, and 
(C) tetrameric UCP2. Average values are shown with dashed lines. As is seen, there is clear change in the 
distribution in both leaflets upon oligomerization of UCP2. 
 




Figure 3-7 APL averaged over the last 50 ns of the simulations for the upper (left panel) and lower (right panel) 
leaflets for the monomeric, dimeric, and tetrameric UCP2. The color is adjusted such that the range gives 50% 
variation over the average (white color ~ 0.6 - 0.7 nm2). Deep blue color represents the protein(s) location. Such 
contours can be considered as UCP2-lipid interaction “fingerprints” 
 
In the current study, we have experimentally shown that UCP2 spontaneously self-associates 
to form tetramers (Mw ~132 kDa) in lipid membranes (Figure 3-1). This tetrameric UCP2 was 
shown to be capable of transporting protons (Figure 3-2), a general characteristic of all UCPs [30, 
CHAPTER 3 - FUNCTIONAL OLIGOMERIC FORMS OF UNCOUPLING PROTEIN 2 
72 
 
66, 68]. On the other hand, AAC1, a mitochondrial carrier protein with comparable three-
dimensional structure to UCP2, does not form tetramers in lipid membranes. These observations 
indicate the specific tendency of UCP2 to form tetramers in phospholipid bilayers, which cannot 
be generalized to all MCF members. Association and stability of the tetrameric state are consistent 
with our previous studies of other UCPs [30, 68] using analytical ultracentrifugation and mass 
spectrometric methods. Importantly, the analysis of salt-bridges from our MD simulations also 
confirms the experimental results [30, 68] that the tetrameric UCP2 complex is in fact a dimer of 
dimers, in which the interactions between the monomers forming the dimer are stronger than the 
interactions between the dimers within the tetramer.  
 
Figure 3-8 Distribution of the lipid head groups (phosphate was used as the marker) in lower (left; matrix 
side) and upper (right; cytoplasmic side) leaflets for all three UCP2 forms. The vertical dashed lines show the 
corresponding averages. The arrow shows a small but persistent contribution of lipid head groups located deep 
inside the membrane; some of the lipids in this band were found to be oriented perpendicular to the membrane 
surface. On the cytoplasmic side, the average values for the monomers and dimers overlap (the blue dashed line is 
behind the orange one). The distribution is different depending on the leaflet and oligomerization state of the 
protein. 
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In addition to the formation and stability of the tetrameric protein, the reversal of the 
ellipticity ratio (θ208/θ222) after reconstitution of the monomeric proteins (from OG detergent) into 
liposomes (Figure 3-3, A) implies both a more compact interhelical packing of monomers and a 
stronger intermolecular interactions between these monomers [30, 68]. The low rate of proton 
transport and its inhibition by common UCP inhibitors such as ATP also confirms that the 
tetrameric UCP2 is functional in lipid membranes and is more likely to be a transporter than a 
channel. This is also supported by the measurements of the free UCP2 monomer radius from the 
MD simulations. 
The MD simulations of the tetramer in the lipid bilayer shows that despite the compaction 
of all constituting monomers over the course of simulation - comparable to changes in the 
ellipticity ratio mentioned in the previous paragraph - these subunits do not adopt similar structures 
and lateral orientations (Figure 3-4). Moreover, asymmetric conformations of monomeric units in 
the tetramer were also observed along the z-axis. Previous computational analyses of the members 
of MCF have proposed two structural states leading to transport of the substrates: 1) the matrix 
state with the protein cavity open to the matrix side and 2) cytoplasmic state with the cavity open 
to the IMS side [46]. It might be concluded from Figure 3-5, A (dashed lines) that every two 
monomers within the dimer are in the same state of transport and there is a phase difference 
between the two sets of dimers in a tetramer (two members of one dimer are in the matrix state 
while the two members of the other dimer are in the cytoplasmic state). The phase difference 
between the dimers within the tetramer and the asymmetric nature of the tetramer could provide a 
scaffold for regulating the activity of individual units, and also facilitate cooperative 
intercommunication between the subunits. Concomitantly, all individual monomeric subunits 
might not be active at the same time. Asymmetric oligomerization has also been reported for other 
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proteins such as tetrameric D‐glyceraldehyde‐3‐phosphate dehydrogenase [248] and dimeric 
tryptophanyl-tRNA synthetase [249]. 
Detailed analysis of the MD data of the interactions stabilizing the dimeric and tetrameric 
UCP2 indicates that comparable salt-bridges are formed between the monomers within the dimer 
and between the monomers within the dimeric units constituting the tetramer (Table A-3-1). No 
salt-bridges were found between the two dimeric units of the tetramer. This finding renders direct 
support to our notion that tetrameric UCP2 is indeed a dimer of dimers (Figure A-3-8). This 
conclusion is further supported by the pulling simulations that showed higher dissociation energy 
of monomeric subunits of a dimer compared to dimeric subunits of a tetramer by 18.5 kcal/mol.  
Further experiments are required to establish the roles of lipid species in the stability and ion 
transport function of UCPs; the role of lipids cannot be easily generalized as has been shown in 
the case ATP binding cassette proteins where results have shown both dependence and 
independence of lipid specificity depending on the systems and properties of interest [250-252]. 
The importance of non-specific protein-lipid interaction is also exhibited in the increased helicity 
of the protein in lipid bilayers (Figure 3-3, A). The role of bridging lipids in stabilizing the 
multimeric complexes of MPs has been shown for several proteins such as dimeric Aquifex 
aeolicus leucine transporter, dimeric E. coli NHE and tetrameric aquaporin (aqpZ) [114]. Finally, 
the scope of in vitro studies is always limited by the use of detergents in MPs purification and 
reconstitution steps, and by not being able to mimic the exact dynamics of the IMM lipid/protein 
membranes. These limitations can lead to deviations from the structure and function of proteins in 
living cells, and the real-time in vivo analysis of IMM, considering the complexities involved, is 
still to be anticipated. 




Detailed structural and ion transport studies and atomistic MD simulations have been utilized 
to investigate UCP2 oligomerization in lipid membranes. The findings suggest a simultaneous co-
existence of functional monomeric, dimeric and tetrameric forms of the protein, under various 
conditions and different membrane lipid compositions. Our experimental data and salt-bridge 
analysis from MD data shows that UCP2 tetramers are dimers of dimers. In addition, MD 
simulations suggest that UCP2 tetramers are asymmetrical, and that there is a phase difference 
between the two sets of dimers in a tetramer. The full implications to proton (or other substrate) 
transport are currently not known, but it can be hypothesized that this asymmetry, which also 
influences the membrane structure, may help to regulate the protein’s activity and communication 
between the individual monomers. 




CHAPTER 4 - ON THE MECHANISM OF PROTON 
TRANSPORT IN UNCOUPLING PROTEIN 2 
4.1 Introduction 
Inducible proton leak across the IMM is accomplished by UCPs [22]. UCPs belong to the 
largest family of solute carriers in humans known as the MCF [46, 60]. UCPs translocate protons 
from the IMS to the matrix, thus dissipating the electrochemical gradient [253] and uncoupling the 
electron transport process from ATP synthesis [253].  
Among the five human UCPs (UCPs 1-5), UCP2 is unique due to its more widespread 
expression in various tissues compared to other members of the family [19, 60, 180]. UCP2 also 
has an important role in regulation of mitochondrial ROS concentration [183-185]. Several studies 
show that the expression of UCP2 is remarkably up-regulated in different types of cancer, 
including cancers of the, skin, prostate, colon, and breast [186-188, 190]. It has recently been 
reported that expression of UCP2 in melanoma is positively related to diffusion of T cells in the 
tumor microenvironment, thus increasing the sensitivity of cancerous cells to therapeutics [189]. 
It has also been suggested that changes in expression levels of UCP2 in various tissues could be 
among the causes of diabetes, obesity and heart failure [254]. 
A NMR structure of UCP2 was reported in 2011 [70]. Although not universally agreed upon 
[59, 64], it is still the only available structure of UCPs in the PDB. Based on sequence similarities, 
UCPs and other members of the MCF are thought to have comparable secondary and tertiary 
structures [46, 60, 70, 207]. These proteins typically contain three domains each comprised of 
about 100 amino acids and folded into two TM α-helices (Figure 4-1, A). Hydrophilic helical 
motifs have been identified in loops that connect the TM helices and that extend into the matrix 
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and IMS [49, 70, 253]. It has been suggested that UCPs function as monomers [83], dimers [66, 
191], and a dimer of dimers (tetramers) [30, 68, and this thesis]; however, these functional forms 
are somewhat controversial, and none have been universally accepted. Controversies are not 
limited to the quaternary structure of UCPs; there is also no consensus on the general or specific 
mechanism of function of these proteins [255]. 
Although proton transport activity is considered to be a common function of all UCPs, its 
detailed mechanism is not yet fully understood. Different studies have shed light on several aspects 
of the proton transport mechanism in UCPs, with a focus on UCP1 [61, 62, 72, 73]. Despite some 
inconsistencies, all agree that proton flux through UCPs is activated by fatty acids and inhibited 
by purine nucleotides [30]. To date, proposed mechanisms of UCP activation by fatty acids can be 
summarized into four models: the fatty acid cycling model [61], the buffering/cofactor model [62], 
the long-chain fatty acid shuttling model [73], and the ITF model [72]. In the fatty acid cycling 
model, protonated fatty acids that reside in the IMS “flip-flop” across the IMM and release their 
proton into the matrix. The fatty acid anion is then transported back from the matrix to IMS by 
UCP [61]. In the buffering model, fatty acid anions bind to the UCP, accept and transport protons 
via their carboxylate group to the buffering amino acids of the protein, one by one, all the way to 
the matrix side through this translocon channel [60, 62]. The shuttling model proposes that 
carboxylate head of a long chain fatty acid moves alongside the protein’s cavity, back and forth 
toward the IMS and the matrix.  It gets protonated in the IMS and deprotonated in the matrix, while 
the fatty acid remains bound to the protein [72, 73]. The ITF model could be considered as a 
modified version of the shuttling model, where in parallel with/as a result of the movement of the 
polar head group of the fatty acid across the IMM, UCPs can alternate between two conformational 
states in which the protein’s cavity is either open to the IMS side (cytoplasmic state) or the matrix 
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side (matrix state) of the membrane [72]. It has been suggested that alternating between the 
cytoplasmic and matrix state in response to substrate binding (alternating access mechanism) is a 
common mechanism of transport in all MCF members [46, 51, 53] (Figure 1-3). 
Based on homology modeling and amino acid alignment of MCF members, two types of 
conserved motifs at the water-accessible interfaces are anticipated to form salt-bridge networks; 
these networks can assist the conversion of cytoplasmic and matrix states through successive 
disruption and reformation of the salt-bridges [51]. The Px[D/E]xx[R/K] motif, located on the odd-
numbered helices (1, 3 and 5), forms the matrix network; and the [F/Y][D/E]xx[R/K] motif, 
located on the even-numbered helices (2, 4 and 6), forms the cytoplasmic network [46, 51]. The 
structure of UCP2 in the cytoplasmic state is depicted in Figure 4-1, A-C; a cone shaped structure 
in which the formation of the matrix network salt-bridges (D35-K141, D138-K239, and D236-
K38) results in narrowing of the matrix side of the protein, and a simultaneous disruption of the 
cytoplasmic network (D101-K295, D198-K10, and E292-K20) leads to the opening of the cavity 
on the IMS side of the protein [51]. Several studies also highlighted the involvement of three 
arginine residues (R88, R185, and R279), located in the vicinity of the matrix network of UCPs, 
in proton transport [52, 63, 72] and transport inhibition mechanisms [52, 63, 74]. A high-resolution 
X-ray structures of AAC1 locked in either cytoplasmic [49] or matrix states [50] provided evidence 
in support of the alternating access model mechanism [50, 56, 76].  
In order to analyze the mechanism of proton transport by UCPs (the second goal of the 
thesis), the role of the matrix network and its electrostatic features in the proton transport 
mechanism of oligomeric UCP2 was investigated. Eleven UCP2 mutants were prepared, of which 
ten had partially or fully disrupted matrix networks (single, double and triple mutants) and one had 
an altered, yet intact, matrix network (Hexamutant, HM) (Figure 4-2). UCP2 and its mutants were 
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expressed in E. coli membranes and reconstituted in lipid vesicles for proton transport and 
transport inhibition analyses. Spectroscopic conformational analyses and thermal stability 
experiments were performed to investigate the structural similarity/stability of UCP2 and its 
mutants in membrane-mimicking environments. MD simulations [134] were also employed to 
provide insights into the local structural changes in tetrameric UCP2 and its mutants and the 
interaction between UCP2 and its inhibitor (ATP in this case). Our results suggest that the matrix 
network plays key roles in both the proton transport regulation of tetrameric UCP2 and the 




Figure 4-1 Sideview (A), and IMS/cytoplasmic (top) view (B and C) of simulated (300ns) structure of UCP2 
in the cytoplasmic state.  An intact matrix network between the residues (cyan) present on odd numbered helices 
(dark orange), and a disrupted cytoplasmic network between the residues (red) present on even numbered helices 
(light orange) is represented. The conserved arginine residues R88, R185, and R279 (blue) can be seen in the 
vicinity of the matrix network. In C, the helices are hidden for clarity and the suggested salt-bridges of the matrix 
network are shown with dashed red lines. The oxygen and nitrogen molecules are shown in red and blue 
respectively. Figure generated by USCF Chimera 1.13rc. 
 




Figure 4-2 Schematic representation of the suggested matrix network in UCP2 and its mutants. disrupted 
salt-bridges are shown with red crosses. Figure generated by PowerPoint 365. 
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4.2 Materials and methods 
4.2.1 Chemicals 
Egg yolk extract with more than 60% (by weight) PC (egg yolk PC or L-α-PC) was obtained 
from Sigma (St. Louis, Missouri).; the remaining ~40% of the egg yolk extract were mostly 
phosphatidylethanolamine and other phospholipids. OG was from BioVision (San Francisco, 
California) and C8E4 was obtained from Bachem (Bubendorf, Switzerland). The fluorescent dye 
SPQ was from Biotium (Fremont, California). The rest of the chemicals were from Sigma-Aldrich.  
4.2.2 Construct design and site-directed mutagenesis 
Four cDNAs, encoding three single mutants (K38Q, K141Q and K239Q) and one double 
mutant (K38Q/K239Q, 2KQ) of UCP2 were generated by site-directed mutagenesis of the wild-
type human UCP2 [30]. Overlap extension PCR was used to incorporate the mutations [256]. The 
recombinant proteins that were produced contained an N-terminal pelB, followed by a His-tag, 
followed by the protein [68]. Codon-optimized cDNAs of the remaining mutants were synthesized 
and cloned into pET26b(+) (Millipore Sigma, Gene synthesis and cloning services provided by 
Biobasic, Markham, ON). The pET26b(+) vector was used for cloning in all cases. The fusion 
proteins produced with a pelB leader sequence on the N-terminus are directed to the cell membrane 
and the pelB leader is cleaved [30, 68]. The recombinant vectors encoding UCP2 and mutants were 
transformed into BL21-Codon Plus- RIPL E. coli (BL21 CD+), or BL21(DE3) cells in the case of 
codon-optimized constructs, by heat shock. 
4.2.3 Overexpression and extraction from membranes  
Recombinant UCP2 and its mutants were expressed in E. coli using the auto-induction 
method as previously described for UCP1 and other UCPs [30, 68, 208]. In brief, E. coli cells were 
grown with vigorous shaking (250rpm) in the auto-induction medium [0.05% glucose, 0.2% 
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lactose, 0.5% glycerol, 0.5% yeast extract, 1% tryptone, 25 mM (NH4)2SO4, 1 mM MgSO4, 50 
mM KH2PO4, 50 mM Na2HPO4,] for 22 hours at 22 °C. After incubation, the cells were spun for 
15 min at 8000 g to collect the bacterial cells (pellets). E. coli cells were resuspended in extraction 
buffer [20 mM Tris-HCl pH 8.0, 500 mM NaCl, 0.2 mg/ml lysozyme, 0.5 mg/ml DNase and one 
ethylenediaminetetraacetic acid (EDTA)-free protease inhibitor cocktail (Roche, Basel, 
Switzerland)]. The cells were lysed by passing three times through a high-pressure cell disruptor 
at 20 kPSi (Constant Systems Limited, Daventry, UK). The cell lysate was spun at 20000 g for 20 
min to remove unwanted cell debris, aggregated proteins, and intact cells. The supernatant was 
removed to a clean screwcap centrifuge tube and centrifuged at 50000 g (MLA 80 rotor, Beckman 
Coulter) for 1 h to pellet the bacterial membranes. 
4.2.4 Purification of UCP2 and its mutants 
Pellets containing bacterial membranes were solubilized and incubated for 15-16 h in 
binding buffer [15 mM imidazole, 1% (w/v) LDAO detergent, 500 mM NaCl, 20 mM Tris- HCl, 
1 mM Tris (hydroxypropyl) phosphine (THP)]. The solution was then rotated with 1 mL of Ni-
NTA resin (Thermo Scientific, Waltham, Massachusetts) for 1 h and transferred to a 0.7 cm 
diameter glass column. The same protocol was used for purification UCP2 and all of its mutants. 
The resin in the column was washed with 15 mM imidazole in 1% OG detergent and eluted with 
40 mM imidazole in 1% OG detergent. The concentration of NaCl, Tris-HCl and THP in wash and 
elution steps were the same as binding buffer. Imidazole was removed from the purified proteins 
(collected upon elution with 40 mM imidazole in 1% OG) by Econo-Pac 10DG Columns (Bio- 
Rad, Hercules, California). Semi-native SDS-PAGE [68] and modified Lowry assay [209] were 
used to assess the purity and concentration of the proteins, respectively [68]. 
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4.2.5 Western blot characterization 
The identity of recombinant UCP2 was confirmed by immunoblotting. 5-10 μg of purified 
recombinant UCP2 was separated using SDS-PAGE and transferred to nitrocellulose using the 
semi-dry method (110 v for 75 minutes). Transfer efficiency was confirmed by Amido-Black 
staining [257]. The filter was blocked for a minimum of 60 min in Tris-buffered saline (TBS) 
containing 5% (w/v) dry skim milk and 0.1% (v/v) tween-20. A 1:2000 dilution of rabbit IgG anti-
UCP1/2/3 (Santa Cruz Biotechnology Inc. Dallas, Texas) was used as the primary antibody for 
detection of UCP2 and HRP conjugated antibody (1:5000 dilution), raised in goat against rabbit 
IgG (Rockland, Limerick, Pennsylvania), was utilized as the secondary antibody. Detection of the 
secondary antibody was achieved using chemiluminescent reagent Luminata Crescendo western 
HRP substrate (Millipore Sigma). The image was captured using a Bio-Rad VersaDoc imaging 
system. 
4.2.6 Reconstitution in lipid bilayers 
UCP2 and its mutants were reconstituted into lipid vesicles by following the procedure 
described in references [30, 80] with minor modifications. Briefly, a thin layer of lipids was formed 
in round bottom flasks by drying solutions of egg yolk PC in MeOH: Chloroform (1:3) for about 
10 hours under vacuum. The thin layer of dried lipids was solubilized in proper reconstitution 
buffer (3mM SPQ fluorescent dye was added for proton transport assays) in order to form 
multilamellar vesicles (MLV). C8E4 [at detergent/lipid ratio of 2.5/1 (w/w)] was added to solubilize 
the MLVs to form mixed micelles. The mixed micelles were supplemented with pure and desalted 
proteins to a final concentration of 3 μM. The molar ratio of lipid to protein was ~6000 and ~600 
for proton transport and CD experiments, respectively. SM-2 Biobeads (Bio-Rad) were finally 
used to remove extra C8E4 and OG in solution resulting in formation of unilamellar 
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proteoliposomes. For proton transport analysis experiments, size-exclusion chromatography 
[Sephadex G25-300 spin column (GE-Healthcare, Chicago, Illinois)] was used for removal of 
external SPQ (SPQ should be encaged inside the vesicles). In parallel to every step of formation 
of proteoliposomes protein-free liposomes were prepared to be analyzed as negative controls. 
4.2.7 CD and fluorescence spectroscopic measurements 
Far- and near-UV CD measurements were performed at 1 nm resolution and at 25 °C, using 
AVIV 215 spectropolarimeter (Aviv Biomedical, Lakewood, New Jersey). For measurements of 
far-UV CD spectra (in OG detergent and in liposomes) quartz cells with 0.1 cm path length were 
used and for measurements of near-UV CD spectra (only in OG detergent) quartz cells with 0.5 
cm was used. Ellipticities were converted to mean residue ellipticity, [θ]. All Individual CD spectra 
were an average of 6-12 measurements. Thermal denaturation curves of UCP2, triple mutants and 
HM in detergents were obtained by monitoring the proteins ellipticity at 222 nm in the range of 
25-90°C [68].  
Steady-state fluorescence of proteoliposomes and blank liposomes was performed at 25°C, 
at a scan rate of 600 nm/min and a band width slit of 5 nm using a Cary Eclipse spectrophotometer 
(Varian, Palo Alto, California).  SPQ was excited at 347 and emission signal was collected at 442 
nm. The fluorescence scans were performed at 25°C. Each reported proton transport rate was 
obtained by averaging of at least 10 different scans. 
4.2.8 Proton transport assay 
Following reconstitution of UCP2 and its mutants in egg yolk PC vesicles the rate of proton 
transport was measured as described previously [80]. In brief, 0.040 mL of vesicles were mixed 
with 1.96 mL of external buffer. The internal buffer of liposomes prepared for proton transport 
measurements was composed of 0.7 mM EDTA, 54 mM tetraethylammonium sulfate (TEA2SO4), 
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and 20mM TES buffer. The composition of the external buffer was similar to that of internal buffer, 
with 54 mM TEA2SO4 replaced by 54 mM potassium sulfate K2SO4. The pH of internal and 
external buffers was 7.2. Proton transport of UCP2 and its mutants was activated by palmitic acid 
at a final concentration of 100 μM. Valinomycin was used to influx K+ and form an electrochemical 
gradient between inside and outside of the liposome which initiates the proton flux of UCP2 and 
its mutants. Efflux of protons by UCP2 and mutants led to deprotonation of TES buffer and 
formation of anionic TES (TES–). TES– is able to quench SPQ fluorescence emission by collision. 
The rate of proton transport by UCP2 and its mutants was thereby correlated to the reduction of 
SPQ signal intensity. The rate of palmitic acid activated proton efflux was evaluated by monitoring 
the reduction of SPQ’s fluorescence signal intensity during the first 0.5 minutes after injection of 
valinomycin [68]. Non-specific proton leakage of blank liposomes was deducted from the proton 
transport rate of the proteoliposome for all cases. Moreover, the proton transport data were 
corrected for internal volume of the liposomes, fluorescence response of SPQ and protein 
concentration [80, 209].  
4.2.9 MD simulations 
The only available NMR structure of UCP2 (PDB ID: 2LCK) [70] was used as the starting 
structure for the monomeric UCP2.  
CHARMM-GUI online server [213] was used to prepare the protein-membrane systems. 
Membranes consist of POPC lipids, since PC is the main constituent of IMM [130, 214]. 
In order to build the tetrameric form, a monomeric system was first prepared and was 
subjected to MD simulation. The final simulated structure was then used to build the UCP2 
tetrameric form. Details of building the tetrameric form is discussed in Chapter 3.  
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The monomeric system was built using 239 POPCs, 11965 water molecules, and 46 and 31 
chloride and potassium ions, respectively. Initial minimization was followed by 1 ns of 
equilibration under NVT and NPT conditions. The production phase included 250 ns.  
For the tetrameric systems, the membranes included (400) POPC lipids. Amino acid 
mutations were made using Pymol [258]. Each system was solvated in an explicit TIP3P [215] 
water box (total of 47881 water molecules) and CHARMM36m/CHARMM36 protein/lipid force 
field were used [216, 217].  
All tetrameric systems were first energy minimized using the steepest descents algorithm 
followed by 2 ns of pre-equilibration under NVT and NPT conditions. MD simulations were 
conducted for 250 ns with 2 ps time steps using GROMACS/2018 [218]. The constraints on the 
chemical bonds were maintained using the linear constraint solver (P-LINCS) algorithm [219]. 
The Nosé-Hoover thermostat [220, 221] with a 1.0 ps coupling constant was employed to maintain 
the temperature at 300 K. To preserve the systems’ pressure, the Parrinello–Rahman barostat [222] 
with a compressibility of 4.5 × 10−5 bar−1 and a 5 ps coupling constant was used. For the long-
range interactions the particle mesh Ewald method [223, 224] was used. The mentioned procedure 
and methods have been employed in a number of previous studies (e.g., Refs. [225, 226, 251])   
and shown to provide reliable results. Root-mean-square deviations were monitored to ensure the 
systems were well equilibrated. 
4.2.10 Statistical analysis and graphical representations  
The statistical method that was used for data analysis was the One-way analysis of variance 
(ANOVA), in which P<0.05 was considered as statistically significant. Graphical representations 
of the proteins were made by USCF Chimera [259] version 1.13rc and Visual Molecular Dynamics 
version 1.9.3 [260].  




4.3.1 Expression, purification, and reconstitution of UCP2 and its mutants 
In order to evaluate the role of the matrix network in the proton transport mechanism of 
human UCP2, eleven mutants were prepared (Figure 4-2), of which ten were generated by single 
or multiple point mutations of K→Q or D→N resulting in partial or full disruption of the matrix 
salt-bridge network. These mutants included six single mutants: K38Q, K141Q, K239Q, D35N, 
D138N, and D236N, two double mutants: K38Q/K239Q (abbreviated as 2KQ) and D138N/D236N 
(2DN) and two triple mutants: K38Q/K141Q/K239Q (3KQ) and D35N/D138N/D236N (3DN). 
Finally, one mutant was prepared by swapping the positions of the lysines and aspartates that 
participate in salt-bridge formation, by simultaneously mutating K→D and D→K, resulting in a 
Hexamutant (D35K/K141D/D138K/K239D/D236K/K38D, abbreviated as HM) with an intact, but 
inversed matrix salt-bridge network. 
 All proteins were expressed in the membrane of E. coli and purified as a mixture of 
monomers, dimers, and tetramers in OG detergent. Purity and identity of all three oligomeric forms 
of UCP2 and its mutants were confirmed by semi-native SDS-PAGE and Western blot analysis 
(using anti-UCP1/2/3 antibody), respectively (Figure A-4-1). Once purified in OG, UCP2 and its 
mutants were reconstituted in egg yolk PC (~60% PC) vesicles for proton transport functional 
analysis. As shown in Figure 4-3, UCP2 and its mutants associated to form a single multimeric 
(tetrameric) complex when reconstituted into liposomes regardless of the number and type of 
mutations. Homo-oligomerization of UCP2 and other UCPs to dimer of dimers in lipid vesicles 
have been demonstrated in our previous reports [30, 68]. The oligomeric structure of UCP2 and 
the interactions involved in the formation of a dimer of dimers in lipidic environments have been 
discussed in detail in Chapter 3 [30, 68]. 





Figure 4-3 Semi native SDS-PAGE analysis of proteoliposomes stained with Coomassie Blue, showing the 
presence of the tetrameric form of UCP2 and its mutants in lipid vesicles. Vertical black lines separate individual 
gels. 
 
4.3.2  CD spectroscopic analysis of UCP2 and its mutants 
Conformations of UCP2 and its mutants in OG detergent were characterized using CD 
spectroscopy. Distinctive spectral features of α-helical backbone secondary structures (two 
negative maxima at 208 nm and 222 nm, and a positive maximum around 193 nm [232]) were 
observed for all proteins (Figure 4-4, A). Also, the ellipticity ratio (θ208/θ222) in all spectra was in 
the range of 0.9-1.0, which is typical of α-helical protein structures [261]. This suggests that 
purified UCP2 and its mutants are dominantly α-helical in OG. Moreover, all twelve proteins 
exhibited conformational similarities, indicating that the mutations did not alter the overall 
conformation of the protein. However, minor local structural differences between UCP2 and its 
mutants were revealed by near-UV CD analysis. Such minor changes in local structures were 
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revealed by up to a ~5 nm red shift of the peak at ~280 nm and/or alteration of the overall shape 
of the near-UV CD spectrum in some cases (Figure 4-4, A, inset). These changes could be due to 
differences in the microenvironment of aromatic residues, especially those close to the site of 
mutations such as W283. 
To ensure that introducing multiple mutations (i.e. in triple mutants and HM) did not affect 
the overall structure of proteins in lipid environments, UCP2 and these mutants were reconstituted 
in lipid vesicles and examined using far-UV CD spectroscopy (Figure 4-4, B). Comparison of the 
far-UV CD spectra before and after reconstitution reveals that CD signals of the reconstituted 
proteins were considerably enhanced compared to those in detergent, indicating that all four 
proteins had higher helical contents in liposomes. This emphasizes the important role of lipids in 
enhancing secondary structures in MPs [201]. Furthermore, spectra of reconstituted proteins 
showed a red shift of the negative maximum at 208 nm (towards 210 nm), which has been 
attributed to enhanced helix-helix interactions and protein association [30, 68, 233-235].  




Figure 4-4 Far-UV CD spectra of UCP2 and its mutants in A) OG detergent and B) in lipid vesicles show an 
overall α-helical structure for all proteins in both environments. Near UV-CD spectra of the proteins in detergent 
(A-inset) indicate that local structure of the mutants at the microenvironment of aromatic residues are comparable 
as well. This suggest that mutations did not impact the overall structure of the proteins. Each reported CD spectrum 
is an average of minimum 6 scans. The concentrations of proteins were 5 – 8 μM in OG and ~1μM in vesicles. 
 
The shape of far-UV CD signals of reconstituted proteins were comparable and 
deconvolution using DichroWeb [155] showed similar helical contents for UCP2 and mutants 
(~50-60%). Despite the similarity of the CD signal of reconstituted proteins in liposomes, slight 
differences were observed in the ellipticity ratio θ208/θ222 (UCP2: 0.74, HM: 0.82, 3KQ: 0.92, 3DN: 
0.95).  Differences in the ellipticity ratios between the mutants and UCP2 could be indicative of 
changes in the degree of protein association and/or alteration of interhelical interactions [68, 233, 
235]. Higher ellipticity ratios of 3DN and 3KQ compared to those of UCP2 and the HM protein 
imply that more relaxed (less compact) conformations could be found in the mutants with disrupted 
matrix network. Collectively, the data indicate that the overall structures of UCP2 and its mutants 
were comparable both in OG detergent and in liposomes. 
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4.3.3 Thermal denaturation experiments 
To further evaluate the proper folding and structural similarity of UCP2 and its mutants with 
multiple mutations (3DN, 3KQ and HM) in OG, the ellipticity at 222 nm was monitored over the 
temperature range of 25-90 ºC. As shown in Figure 4-5, A, UCP2 and all three mutants showed 
comparable cooperative denaturation curves and with no significant difference (P>0.05) between 
the melting points (Tm). The Tm of UCP2 in these experiments was 59.8 ± 0.7 ºC, which is very 
close to the reported Tm of the prototypical UCP1 in OG (Tm= 59.2 ºC) [68], and relatively close 
to that of AAC in dodecyl-maltoside detergent plus CL (Tm=50.0 ºC) [262].  
 
Figure 4-5 A) Comparative thermal denaturation curves of UCP2 and its mutants in OG 
reveal that multiple mutations of UCP2 did not impact the thermal stability of the protein. B) 
Thermal denaturation curve of UCP2 in the absence and presence of ATP shows an 
increase in Tm upon addition of ATP (indicated by the arrow) as a result of formation of new 
salt-bridges between ATP and UCP2. Tm was calculated by Boltzmann equation for fitting the 
data.   
 
 
Appropriate folding of extracted proteins from bacterial membranes was further supported 
by the elevated Tm of the proteins after addition of their inhibitor ATP (Figure 4-5, B). Elevation 
of UCP2 Tm to 61.8 ± 0.4 ºC in the presence of ATP suggests that UCP2 interacts with ATP and 
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is folded in its native-like functional form, which provides an appropriate binding site for the 
inhibitor. Addition of ATP to 3DN and 3KQ also increased the Tm in both cases, albeit less 
compared to that for UCP2 (the increase of Tm was 2.0 ºC, 1.2 ºC, and 1.4 ºC for UCP2, 3DN and 
3KQ, respectively). This could be a consequence of direct or indirect impact of the mutations in 
the interaction with ATP (discussed later).  
Overall, denaturation experiments specified that UCP2 and its mutants were relatively stable 
in OG detergent, and neither extraction and purification steps, nor multiple point mutations 
resulted in loss of structural stability. 
4.3.4 The role of the matrix salt-bridge network on proton transport function of UCP2 
Proton transport rates were studied using a fluorescence quenching assay, as described 
previously (Figure A-2-1) [80]. All proteins were only able to transport protons after addition of 
palmitic acid (PA). This is consistent with previously reported data on the inability of UCP1 (in 
proteoliposome systems and mitoplasts) to transport protons in the absence of free fatty acids [72, 
263]. Table A-4-1 and Figure 4-6 represent proton transport rates of UCP2 and its eleven mutants. 
The rate at which UCP2 transported protons was 5.24 ± 0.09 μmol/min/mg protein, which is within 
the range of previously reported proton transport rates for UCP2 (1.2-30 µg/min/mg protein) [for 
a full list see Ref. [80]]. Our results showed that disruption of the matrix network by elimination 
of the charged residues (K→Q and D→N mutations) significantly (P<0.05, P less than 0.05 means 
a significant difference between the results was obtained in our SPSS, One-Way ANOVA test) 
increased the rate of proton flux. In contrast, mutations that maintained the integrity of the matrix 
network did not affect the proton transport rate as no significant difference was observed in the 
proton transport rate of UCP2 and the HM version (P>0.05). 




Figure 4-6 Proton transport rate of UCP2 and its mutants. Mutations of K → Q are shown in orange shades 
and mutations of D→N are shown in blue shades. For the numerical values see Table A-4-1. Every two bars 
close to one another were predicted to disrupt the same salt-bridge(s). The full length of each bar represents the rate 
of proton transport in the absence of ATP and the darker shade on the bars shows the rate of proton transport in the 
presence of ATP. Each bar represents the average transport rate of 10 repeats and the error bars show the standard 
deviations. 
 
To compare the structural features of the proteins at the site of the matrix network, atomistic 
MD simulations were carried out on tetrameric UCP2 (Figure A-4-2) and selected mutants 
(D138N, 2DN, 3DN, 3KQ, and HM) in a POPC bilayer. Interestingly, MD simulation analyses 
showed that the matrix network is composed of more salt-bridges than what has been previously 
suggested [51]. In fact, instead of the three suggested salt-bridges between aspartate and lysine 
pairs of the signature motifs on odd numbered helices (D35-K141, D138-K239 and D236-K38), 
the MD simulations indicate that the matrix network is composed of five salt-bridges (D35-K141, 
D138-K239, D138-R88, D236-R185, and D236-R279) of which two are amongst the previously 
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suggested matrix network and three are formed upon interaction of aspartate residues of the 
signature motifs with R88, R185 and R279. Consequently, in order to properly investigate the role 
of the matrix network in proton transport by UCP2 all potential salt-bridges should be considered.  
Figure A-4-3 represents a single snapshot (at 250 ns) of the matrix network in the four 
monomeric subunits of tetrameric UCP2 (labelled as chains A-D). The average length of the matrix 
network salt-bridges over the last 100 ns of simulation are listed in Table 4-1. A 0.4 nm cut off 
was used to determine salt-bridge formation [264]. Even though the distances between the residues 
of the three originally suggested salt-bridges are reported in this table, K38 and D236 did not form 
a salt-bridge in any of the subunits (average distance > 0.4 nm) during the simulations. RMSD 
analysis (Figure A-4-4) showed that all the systems have reached equilibrium and the proteins did 
not completely or partially change their conformational state (from matrix state to cytoplasmic 
state and vice versa) over the last 100 ns. Table 4-1 reveals that the matrix network did not have 
similar conformations in the four subunits of UCP2; e.g., the salt-bridges that were formed within 
chain A of the wild-type UCP2 (D138-R88, D236-R185 and D236-R279) were different from 
those in chains B, C, and D. This is consistent with our recent work showing that individual 
subunits do not obtain 100% identical conformations (Chapter 3) and the tetrameric UCP2 is in 
fact a pseudosymmetrical dimeric complex of dimers. The dissimilarity between the matrix 
network salt-bridges of UCP2 subunits (also seen in mutants) implies that not all subunits are in 
the same phase of transport, which means protons do not enter and exit all four subunits 
concurrently.  
Comparison of UCP2 and D138N tetramers indicated that upon single mutation of D→N 
more than half of the salt-bridges of the matrix network were lost (changed from a total of 12 per  
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Table 4-1 Average distance (nm) for salt-bridges in different system over the last 100 ns of simulation. 
 
-The salt-bridges shown with * sign did not form in the UCP2. 
-The originally proposed salt-bridges are shown in black, the interactions involving arginine residues are shown in 
blue, and the numbers ≤ 0.40 nm (the salt-bridge cut off) are shown in bold. 
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tetramer to a total of 5). This decrease in the number of salt-bridges together with ~2 times increase 
in the rate of proton transport (Figure 4-6) suggest an important “filtering” role for the matrix 
network in limiting the proton leakage across the protein. The total number of salt-bridges in 
tetrameric 2DN and 3KQ was found to be 4 and 6, respectively (comparable to that of D138N). 
This agrees with the similar rates of proton transport observed in D138N, 2DN and 3KQ (P>0.05). 
The data suggest that the matrix network of UCP2 is interconnected, and disruption of one 
component could impact other components; thus one single mutation can reduce the filtering effect 
of the network as much as three mutations (3KQ) (in the network) can do. As shown in Table 4-1, 
our MD simulations showed no salt-bridge formation in the matrix network for 3DN, the mutant 
with the highest rate of proton transport (31.26 ± 0.09 μmol/min/mg protein). Such uncontrolled 
proton leakage could be a result of total loss of the filtering effect of the matrix network. Moreover, 
the significant contribution of newly identified salt-bridges (D138-R88, D236-R185, and D236-
R279) in controlling proton leak across UCP2 could be distinguished upon comparison of the rate 
of proton transport by 3DN and 3KQ. In both mutants all original K-D salt-bridges of the matrix 
network were disrupted, thus the difference in the rate of proton transport (11.82 ± 0.48 for 3KQ 
vs. 31.26 ± 0.95 for 3DN) could be related to the difference in the number of the newly identified 
salt-bridges (6 in 3KQ vs. 0 in 3DN). Finally, the only mutant with similar number of salt-bridges 
to UCP2 was HM (12 salt-bridges per tetramer), which also showed a comparable rate of proton 
transport with UCP2 (P>0.05). Overall, the proton transport results suggested that the rate of 
proton transport is inversely related to the number of salt-bridges per tetramer: UCP2 and HM > 
3KQ > D138N > 2DN > 3DN, (Table A-4-1). 
Importantly, MD simulation analyses together with our experimental approach strongly 
supported a cooperative tetrameric function for UCP2 (and its mutants). In all cases, the four 
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subunits were analyzed as one interconnected tetrameric unit and the total number of salt-bridges 
per tetramer were considered. Our results also showed a correlation between the proton transport 
rate and structural compactness of UCP2; mutants with a more relaxed conformation (less compact 
monomeric units) compared to UCP2 showed increased proton transport rates, while the HM 
protein, with similar interhelical packing to that of UCP2, had a comparable proton transport rate. 
Such correlations were previously reported by Hoang et al. [32]. 
4.3.5 Inhibition of proton transport by ATP 
In order to investigate the mechanism of inhibition of proton transport by purine nucleotides, 
the proton flux rate of UCP2 and its mutants was analyzed in the presence of ATP (Figure 4-6 and 
Table A-4-1). Molecular features of the interaction of UCP2 with ATP were also analyzed using 
MD simulations. The highest rate of inhibition (~78%) was observed for UCP2, decreasing the 
rate of proton transport to 1.17 ± 0.09 μmol/min/mg protein. Partial inhibition of UCPs by purine 
nucleotides has been reported previously in several studies [71, 80].  Figure 4-7 shows a snapshot 
of UCP2 and ATP contacts at 250 ns. Arginine (R88, R185 and R279) and lysine residues (K38, 
K141 and K239) of the matrix network could interact electrostatically with the phosphate groups 
of the ATP molecule (Figure 4-7 and Table 4-1) in all four subunits of the tetrameric UCP2 leading 
to tight binding of protein to its inhibitor (one ATP molecule/every subunit). Binding to ATP was 
not identical among the subunits of UCP2 neither in terms of the number of interactions nor in the 
interacting protein residues involved (for example in subunit A, ATP was interacting with K141, 
R88 and R279 while in subunit B it was interacting with K38, R88 and R279 but not K141) (Figure 
4-7 and Table 4-1). Therefore, the experimental inhibition rate (~78% inhibition) could be an 
average outcome of four different types of UCP2-ATP contacts. A basal proton leak might take 
place in subunits which are less tightly bound to ATP, which explains the reason behind not 
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reaching a 100% inhibition by purine nucleotides [71, 80]. Residues R88, R185, R279 and K141 
were previously proposed as potential binding sites of purine nucleotides in the structure of UCP2 
[30, 63, 74]. To the authors’ knowledge, residues K38 and K239 are reported for the first time in 
this study as potential binding sites of ATP. 
 
 
Figure 4-7 The interactions between ATP and subunits A-D of the tetrameric UCP2 (top view from the IMS 
side). Protein helices are omitted for clarity. Average length for the interactions is provided in Table 4-1. Carbon, 
nitrogen, and oxygen are shown in cyan, blue, and red, respectively. Carbon and phosphorous of the ATP molecule 
are shown in yellow and orange, respectively. Figure generated by VMD 1.9.3. 
Since a total of six residues were able to interact with ATP, mutations of K→Q and D→N 
could only lower (but not fully interrupt) the inhibition mechanism, thus the rate of inhibition was 
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in the range of ~ 50-60% (Table A-4-1) for such mutants. Even though aspartate residues did not 
directly bind to ATP, the inhibition rates of K→Q and D→N mutants were comparable. This 
observation implies that D→N mutations indirectly influenced the inhibition process by 
conformational distortions that could result in loosening the packing of helices near the binding 
site of ATP and/or lowering the availability of ATP-interacting residues. The similarity (P>0.05) 
of inhibition rate between the HM and UCP2 supports the importance of tight helix-helix 
interactions in binding of UCP2 to ATP. The data suggest that ATP can bind to the center of 
monomeric subunits of the UCP2 tetramer upon interaction with basic residues of the matrix 
network and the integrity of the network impacts this binding. 
Binding of ATP to UCP2 resulted in increased thermal stability (higher Tm) of the protein 
(Figure 4-5, B). Addition of ATP to 3DN and 3KQ also increased the Tm; however, to a lesser 
extent. This is consistent with the lower inhibitory effect of ATP on triple mutants compared to 
that for UCP2 (Table A-4-1 and Figure 4-6), and the importance of local structure in UCP2-ATP 
interactions. 
4.4 Discussion 
Signature motifs present on helices 1, 3, and 5 of MCF members have been suggested to 
form matrix salt-bridge networks in multiple studies [46, 51, 56]; however, it seems that this 
suggestion was extrapolated from structural analysis of AAC1 in the presence of CATR inhibitor 
[49, 265]. Here we demonstrated the engagement of arginine residues 88, 185 and 279 in the matrix 
network of human UCP2 and provide evidence of a more complex network compared to what was 
originally proposed [51]. Similarly, a more complex and broader matrix network has recently been 
offered for AAC1 (without inhibitor) based on MD simulation analyses in POPC [265]. Under our 
experimental conditions, low proton transport rates of UCP2 and its mutants were in better 
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agreement with the behavior of a transporter/carrier as compared to an ion channel [72]. However, 
the possibility of increased transport rates under different physiological conditions [such as larger 
electrochemical potential across the mitochondrial membrane and interactions of other proteins 
and specific lipids (such as CL) in the IMM)] cannot be excluded.  
A combination of the electrophoresis (Figure 4-3), CD (Figure 4-4), thermal denaturation 
(Figure 4-5) and proton transport (Figure 4-6 and Table 4-1) analyses of UCP2 and its mutants 
revealed that the mutations did not have a substantial impact on the overall conformation and the 
molecularity of the proteins in lipid-like environments. The differences in proton transport rates 
can thus be attributed to the disruption of the salt-bridge network and its relative impact on local 
conformation rather than perturbing the overall tertiary structure of the proteins. 
By comparing the proton transport rates and structures of UCP2 and its mutants, we can 
conclude that the matrix network plays a dual role in regulating the proton transport function of 
UCP2. First, by formation of a cumulative electric field as a result of electrostatic interactions 
between lysine and arginine residues with aspartates, which can have a filtering effect on proton 
transport. Secondly, by holding the TM helices in the monomeric subunits close to one another, 
enhancing their non-covalent interactions, and maintaining the dense packing of the funnel-like 
structure of the protein. The regulatory role of the matrix network is consistent with the reported 
gating role of cytoplasmic and matrix networks of MCF members to prevent undesirable proton 
leak across the IMM [46]. 
Structural differences in the local interior conformations and the matrix network states 
(Figure A-4-3 and Table 4-1) of the monomeric subunits of tetrameric UCP2, indicate that the 
subunits do not undergo identical changes concurrently and there might be a phase difference in 
the transport cycle of the neighboring subunits. In Chapter 3 we analyzed the internal cavities of 
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all four subunits of UCP2 along the central z axis normal to the membrane aided by MD 
simulations and found that in UCP tetramers the orientation of cavities of monomers in each 
dimeric subunit was similar but opposite to the monomers of the other dimeric unit (Figure 4-8). 
In other words, in tetrameric UCP2, monomers in one of the dimers were open towards the IMS 
and the monomeric subunits of the other dimeric pair were open towards the matrix side of the 
membrane. This two-state or biphasic conformation of UCP tetramers could be the functional 
mode of the protein in ion/proton transport. For example, for the proton transport function of the 
tetrameric UCP2, on the basis of this two-state model, it can be suggested that one of the two 
dimeric units that is open to the IMS side (cytoplasmic state; closed to the matrix side) allows the 
protons to enter the open cavities of its monomeric subunits (open mode); while, simultaneously, 
the other dimeric unit that is closed to the IMS side (matrix state; open to the matrix side) does not 
allow protons to enter from the IMS side of the membrane (closed mode) (Figure 4-8). These open 
and closed functional modes of the protein are interconvertible but always oppose each other. To 
better understand the synchronicity in the biphasic behavior of UCP2, one can visualize the dimeric 
unit in the cytoplasmic state (or open mode) is about to absorb protons from the IMS side, and at 
the same time the dimeric unit in the matrix state (or closed mode) is about to release protons to 
the matrix side (matrix state). At a certain stage of proton absorption on the IMS side and proton 
release on the matrix side the dimeric units in the protein inverse their conformations and in the 
next stage their roles switch. This general biphasic two-state molecular model (Figure 4-8) 
primarily aims to explain the proton transport in tetrameric UCP2 (and other UCPs). In addition, 
this general biphasic model could also help explain the co-transport (antiport) of protons and 
certain anions (such as chloride) in tetrameric UCPs [30]. The matrix state of the dimeric units 
with low affinity for positively-charged protons could have a high affinity for anions such as 
CHAPTER 4 - ON THE MECHANISM OF PROTON TRANSPORT IN UNCOUPLING PROTEIN 2 
102 
 
chloride; therefore, after being attracted to the open cavity of the matrix state (with a positive 
electric field), chloride ions will have an opportunity to be transported to the IMS side of the 
membrane after conversion of the matrix state to cytoplasmic state.  
To summarize, all subunits are functional in a tetrameric UCP2 complex, monomers of each 
dimer are in similar transport states (cytoplasmic or matrix states), and the function of one dimeric 




Figure 4-8 The biphasic two-state model for proton transport and inhibition of tetrameric UCP2. The 
monomeric subunits within a dimeric unit are functional and conformationally correlated. Dimeric unit 1 (yellow) 
is in cytoplasmic state first and changes to matrix state as the protonated head group of fatty acid moves form the 
IMS towards the matrix. Dimeric unit 2 (green) is in matrix state first, and changes to cytoplasmic state upon the 
movement of fatty acid’s head group towards the IMS. None of the four monomeric subunits of the tetramer have 
identical conformations; however, the monomers within one dimeric unit are at the similar conformational state or 
phase (compare the subunits with the same color) which is opposite to the second dimeric unit (compare yellow 
and green subunits).  Fatty acids are shown in deprotonated (black) and protonated (red sphere attached) forms. 
Fatty acids are protonated in the cytoplasmic state and deprotonated in the matrix state. Conformational changes in 
one dimeric unit can simultaneously induce change of conformation in the other dimeric unit. Binding of ATP 
(orange) locks the conformational changes of the proteins and blocks the path of fatty acid. Figure generated by 
PowerPoint 365. 
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4.4.1 Mechanism of proton transport by the subunits of a tetrameric UCP2 complex  
The mechanism of proton transport by monomeric subunits of the tetramer in the proposed 
two-state model could be explained by the ITF model, describe above [72]; however, in a 
tetrameric complex the transport mechanism becomes more complicated as the subunits mutually 
impact one another (Figure 4-8). Based on the ITF model, when a UCP2 monomer is in the 
cytoplasmic state (intact matrix network) a long chain fatty acid and a proton can interact with 
three arginine residues (R88, R185, R279) present at the center of the protein and induce a set of 
conformational changes which eventually transforms the protein to the matrix state [72]. When 
UCP2 is in the matrix state (disrupted matrix network), the arginine residues and the protonated 
fatty acids are exposed to the matrix side where the proton is released [72]. Another set of 
conformational changes is required to return the fatty acid back to the IMS side in order to start 
another transport cycle [72]. The fatty acid’s hydrocarbon chain remains anchored to its binding 
site (hydrophobic pocket) on the protein by hydrophobic interactions throughout the transport 
cycle [72]. The fatty acid’s head can move back and forth across the protein upon changes from 
cytoplasmic to matrix state and vice versa. Very similar mechanisms have been proposed for the 
symport of protons and anionic species across the IMM by other members of the MCF, such as 
PICs and glutamate carriers [57]. The ITF model can be expanded to the dimeric units of the 
tetrameric UCP2, assuming that each unit binds to two fatty acids (one for each monomer) and is 
either protonated (cytoplasmic state) or deprotonated (matrix state). However, based on the 
inherent asymmetry of monomeric subunits in UCP2 (Chapter 3), it is feasible that dissimilar 
asymmetric conformations of monomeric subunits offer different binding affinities for fatty acids 
and one or more of these subunits may not even properly bind to fatty acids (therefore not active). 
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Stoichiometry of fatty acid to protein subunit in tetramer may therefore be different from the 1:1 
stoichiometry in the monomer.  
This possibility brings us back to the potential regulatory role of the matrix network in proton 
transport, which could be assisted by cooperative interaction of UCP2 non-equivalent subunits. 
The inverse relationship between the packing density of the TM helices and the rate of proton 
transport (comparison between the native protein and single, double and triple mutants) could be 
related to easier movement of fatty acid across the protein in mutants with disrupted matrix 
network. The ITF mechanism supports the observed elevation of UCP2 proton transport function 
by increasing the fatty acid chain length [32]. In this case, stronger hydrophobic interactions in 
longer hydrocarbon chains enable the fatty acid to remain bound and participate in more transport 
cycles. The ITF hypothetical model may also explain the inhibitory role of fatty acids on the 
chloride transport function of UCP2 reported previously [30]. Since the fatty acid and chloride 
might share the same path, the anionic form of the fatty acid (present in the matrix state of the 
transporter) could interrupt chloride transport from matrix to IMS. 
4.4.2 Cycling and buffering models  
We have reported that the chloride transport rate of UCP2 was much less than its proton 
transport rate [30, 32]. This conflicts with the fatty acid cycling model in which the anion transport 
activity of UCPs is a prerequisite of their proton transport function [61, 76]. Moreover, the passage 
of a fatty acid hydrocarbon tail from the relatively hydrophilic core of UCP2 seems to be 
energetically unfavorable and should be lowered (should not be enhanced) as the hydrophobicity 
and bulkiness of the hydrocarbon chain increases, yet we saw a direct relationship between the 
length of the fatty acid and the proton transport activity of UCP2 [30, 32]. Also, bulky and long-
chain fatty acids such as arachidonic acid have been shown to activate UCP2 at a higher rate than 
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shorter and less bulky fatty acids [30, 32]. The fatty acid cycling model was proposed based on 
the ability of the AAC to transport anionic fatty acids [19, 61], however, a recent patch clamp 
analysis clearly showed the inability of AAC to transport such species [90]. 
Our results do not support the buffering model either [62]. First, because neutralization of 
titratable residues of the matrix network resulted in a higher rate of proton transport compared to 
UCP2, which is in contrast with the stepwise passage of protons to titratable amino acids. 
Secondly, partial or full disruption of the matrix network considerably increased the transport rate 
of protons, and in the buffering model no role was identified for any of the two networks. 
Furthermore, the observed inhibitory role of fatty acids on chloride transport of UCP2 (and other 
UCPs) [30] could not be explained by the buffering model. 
4.4.3 Inhibition of proton transport with ATP 
Upon disruption of the matrix network and formation of new salt-bridges with basic residues 
(K38, K141, K239, R88, R185, and R279), MD simulations revealed that ATP could bind to UCP2 
in its cytoplasmic state at a position near the center of the cavity (Figure 4-7). ATP binding might 
block the movement of fatty acid, preventing it from moving between the IMS and the matrix, 
thereby stopping the protein from changing conformation or locking it in an intermediate state 
(neither cytoplasmic nor matrix state). ATP inhibition might also be attributed to neutralizing the 
positive charges of the arginine residues through interaction with the phosphate groups. These 
arginine residues (R88, R185 and R279) have been proposed to attract fatty acids towards the 
protein cavity to initiate proton transport [72]. Our hypothesis on the presence of ATP in the 
translocon channel of UCPs and its interaction with matrix network residues is consistent with a 
previous report on the ability of ATP to induce a local conformational change in UCP1 with minor 
alteration of the overall protein structure [68].  
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In our mechanistic model supported by MD simulations, similar to the case of fatty acid 
binding in proton transport, each of the four ATP molecules can have different binding affinities 
for non-equivalent monomeric subunits of UCP2. Considering the influence of local conformation 
of the protein cavity in the cytoplasmic state on ATP interaction with UCP2 and the mutual 
interaction of subunits within the tetrameric functional unit (discussed above), we conclude that 
intercommunication between subunits could dictate the rate of inhibition.  
4.5 Conclusions  
In the current study we suggest a model for proton transport in tetrameric UCP2 that we term 
the biphasic two-state proton transport model. We also introduced the possibility of a larger matrix 
salt-bridge network (composed of five salt-bridges D35-K141, D138-K239, D138-R88, D236-
R185, D236-R279 of which the last three have never been reported previously) for UCP2 and 
demonstrated that the matrix network plays an important filtering role in controlling proton 
transport. Based on this biphasic two-state proton transport model for tetrameric UCP2 (Figure 4-
8), the conformation of each functional dimeric unit is either in one or the other mode of transport, 
acting as an on /off switch. The presence of ATP can occlude the translocon channel via interaction 
with specific basic residues (K38, K141, K239, R88, R185, R279), and also inhibit proton 
transport by preventing switching between the cytoplasmic and matrix state conformational 
changes as well as movement of fatty acids. 




CHAPTER 5 - CONCLUSIONS AND FUTURE DIRECTIONS 
UCPs have attracted a great deal of attention since their discovery in 1978. A total of ~17000 
studies have been published on UCPs to date, of which about half have been in the last decade 
(Figure 5-1) [266]. This is because UCPs not only mediate non-shivering thermogenesis in 
mammals, but they have also been linked to several metabolic diseases (such as obesity, diabetes, 
hypertension and cancer), making them intriguing drug targets [19].  
 
 
Figure 5-1 Number of published documents per year, with the phrase ‘uncoupling proteins’ in the abstract, 
title and keywords. The graph is obtained from Scopus analysis website Ref. 266 
 
To treat obesity, energy intake should be less than expenditure and increasing uncoupling 
activity causes the cell to consume more energy in order to generate the same/required amount of 
ATP. Several chemical agents induce mitochondrial uncoupling; however, these agents have 
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serious side effects on human health [45]. Activation of UCP1 has shown promising effects in the 
regulation of body weight in mice and human studies and, contrary to chemical anti-obesity drugs, 
might have additional metabolic benefits [45]. The physiological functions of UCPs 2-5 are less 
well defined than that of UCP1. But several studies show that UCP2 can regulate/balance ROS 
formation [45, 183, 267, 268]. Furthermore, expression of UCP2 in tumor cells makes them more 
resistant to anti-tumor agents [254]. It has been reported in different studies that inhibition, down 
regulation and decreased expression levels of UCP2 in cancer cells result in increased sensitivity 
of tumors to various chemotherapeutic agents [254].  
Despite their important potential as therapeutic targets, UCPs’ structure and mechanism of 
activation are not clear. Even though the NMR structures of UCP1 [69] and UCP2 [70] have been 
reported, but there is not overall agreement on the functional structures of UCPs and their state of 
oligomerization [59, 255]. Inconsistencies about UCPs’ mechanism of function, structure and 
primary substrates mostly originate from differences in protein preparation and functionalization 
methods [59, 255].  
With the goal of making a contribution to the current knowledge on UCPs, the current study 
reports new findings on the structural features and mechanistic aspects of UCP2 proton transport 
at the molecular and atomic levels.  
Experimental and computational results from this thesis support self-association of UCPs 
into tetramers, as dimers of dimeric units, in lipidic environments.  The study highlights the 
residues that play key roles in maintaining UCP2 structure and function, such as those involved in 
subunit association or essential residues in proton transport activation and inhibition. The research 
also demonstrates the structural changes that the protein and its surrounding bilayer undergo upon 
oligomerization and reveals the importance of the subunit’s internal cavity conformation and inter- 
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and intra-subunit helix-helix interactions/associations during proton/anion transport activity of 
UCP2.  Finally, by focusing on one of the main constituents of the alternating access mechanism 
(the matrix network, explained in the Introduction section), the main outcome of this thesis is 
summed up in a molecular model describing proton transport by tetrameric UCPs. This model can 
provide insights into the regulation of uncoupling activity in biological environments.  
5.1 UCP2 self-associates as a pseudosymmetric dimer of dimers in model lipid membranes 
Oligomerization of MCF members in the IMM has long been a subject of controversy [66, 
68, 116]. As mentioned in the Introduction section, the molecular states of proton transporters of 
the MCF has been debated among researchers in the field and UCPs are not an exception in this 
regard. In the case of UCPs, the existence of monomeric [83] and dimeric [65] functional states 
have been suggested previously by some researchers and the tetrameric functional state has been 
suggested by our group [30, 68]. This thesis, using both experimental and computational 
methodologies and approaches, provides additional support and evidence for the tendency of 
UCP2 to form tetramers (dimer of dimers) in model lipid membranes. We observed that regardless 
of the starting molecular state of UCP2 used for reconstitution, the protein spontaneously 
assembles into tetrameric complexes when reconstituted in lipid membranes (Figures 3-1 and 3-
2).  
The structure of the UCP2 tetramer in a PC bilayer was also characterized using 
computational methods, which revealed that this functional tetramer is likely a 
pseudosymmetric/asymmetric dimer of dimers capable of inducing asymmetry in the bilayer 
leaflets (Figures 3-7 and 3-8). Each dimeric unit (in a UCP2 tetramer) was stabilized via formation 
of salt-bridges and hydrogen bonds between the two monomers; however, no salt-bridges were 
formed between the two dimeric units within the tetramer. Furthermore, the energy needed to 
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dissociate the dimers to monomers was higher than that needed to dissociate the tetramers to 
dimers. Our data suggest that UCP2 is a dimer of dimers with two different interfaces, one loose 
interface between the two dimers and one tight interface between the two monomers within the 
dimeric unit, the findings of the current thesis are consistent with our original reports about the 
possibility of UCPs to exist as dimer of dimers [68]. Formation of salt-bridges between monomeric 
subunits of MPs is a critical factor in stabilizing oligomers and their ability to self-oligomerize 
without the need for lipids [114]. In other words, the presence of two salt-bridges stabilize the 
dimeric units, independent of lipids. Conversely, lack of salt-bridges between the dimeric units 
result in a loose association that may require lipids at the interface to stabilize. This might suggest 
that UCPs could exist as dimeric units in the membrane with capability to further oligomerize to 
form a functional tetramer. Equilibrium between two oligomeric states in response to factors such 
as alteration of membrane lipidic composition have been reported previously for other proteins 
such as bacterial sugar transporter SemiSWEET [114]. Furthermore, it has been reported that the 
presence of lipids such as CL in the model membranes could promote the ion transport ability of 
UCP2 (and other UCPs) [80]. Thus, changing the membrane lipid composition is a possible signal 
that could regulate the abundance of the functional tetrameric UCP2.  
Computational conformational analysis of the asymmetric UCP2 tetramer showed a biphasic 
molecular structure (Figure 3-5), meaning that  the monomers within the dimeric units have 
comparable (but not necessarily equivalent) conformations with their cavities exposed to one side 
of the membrane, and the dimeric units have opposite orientations. For example, the two 
monomers within one dimeric unit had cavities open to the matrix (matrix state), while the two 
monomers in the other dimeric unit had cavities open to the IMS (cytoplasmic state). This 
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tetrameric structure implies a cooperative interconnection between the two dimeric units where 
the conformational of one unit could impact the conformational changes of other units. 
To validate our experimental methods, and to evaluate the oligomeric state of other MCF 
members we purified AAC as a mixture of monomers and dimers using the same methods as were 
used for UCP2, and observed that reconstitution did not induce oligomerization as was the case 
with UCPs (Figure 3-1). We also applied similar computational analyses to both proteins to 
compare the structural features of UCP2 and AAC; these proteins behaved differently, supporting 
the experimental results.  
To observe the structure of UCPs in lipid membranes by experimental methods in the future, 
these proteins can be analyzed by mass spectroscopy techniques [115]. Recent advances in this 
technique allow for the study of specific and nonspecific lipid interactions with proteins in order 
to determine the role of lipids in inducing oligomerization in cell membrane mimics [115]. 
Furthermore to evaluate the role of specific lipid species on oligomerization (such as CL, which is 
proposed to play a significant role in oligomerization of MCF members), UCPs could be expressed 
in bacteria with specific lipid deficiencies such as CL deficient E. coli [114]. Such strains provide 
the opportunity to better control the lipid environment and compare the impact of presence and 
absence of these molecules on oligomerization.  
UCP proteoliposomes could also be studied by atomic force microscopy (AFM) in imaging 
mode [269] in the future. AFM is able to scan surfaces with sub-nanometer resolution, thus can 
visualize protein folding, oligomeric states, and height [269]. Human aquaporin 1 (six TM helices) 
is an example of a MP for which the tetrameric structure has been visualized using AFM [270]. 
CHAPTER 5 - CONCLUSIONS AND FUTURE DIRECTIONS 
112 
 
5.2 UCP2 transports protons as a biphasic dimer of dimers 
Fatty acid-activated proton transport is a well-defined function of all UCPs [80]. But the 
exact mechanism of UCP activation by fatty acids and inhibition by purine nucleotides is not 
universally agreed upon. Various research groups have proposed different models of proton 
transport by UCPs (see section 1.6.1) [61, 62, 72, 73]. The existence of multiple models may have 
arisen because of dissimilar experimental approaches and sometimes incomplete interpretation of 
the data [255]. The alternating access mechanism model (Figure 1-3) was proposed as a common 
mechanism of non-regulated proton transport by all MCF members [51]. A recent whole cell patch 
clamp study on mitoplasts from various mouse tissues demonstrated that UCP1 and AAC are both 
fatty acid-activated proton transporters of the IMM and unequally responsible for regulated proton 
transport in mitochondria, with UCP1 as the main transporter [90]. Patch clamp analyses also 
supported the alternating access mechanism in both proteins and suggested that alternation 
between cytoplasmic and matrix states occurs in parallel to shuttling of fatty acids across the 
protein’s interior [90].  
In the current study, we examined the importance of one of the main functional elements of 
the alternating access model - the matrix network - by investigating the structure and proton 
transport activity of UCP2 and eleven mutant versions. Extensive structural evaluation of UCP2 
and the mutants revealed a more comprehensive matrix network than had been previously 
proposed, consisting of five (instead of three) salt-bridges (D35-K141, D138-K239, D138-R88, 
D236-R185, D236-R279), which was not only able to act as an electric filter to prevent basal 
proton leak across UCP2, but also could hold the helices close to one another on the matrix side 
giving rise to the V shape (conical) structure of the cytoplasmic state. Both of these roles agree 
with the proposed role of the matrix network in the alternating access mechanism [51]. 
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Consistent with the apparent pseudosymmetrical structure of UCP2, we observed that 
monomeric subunits of the UCP2 tetramer do not undergo similar changes during the transport 
cycle (Figures 3-4, A-4-3, and Table 4-1); however, their change of conformation could impact 
one another. This observation together with the biphasic tetrameric conformation of the protein 
(Figure 3-5), led us to suggest a biphasic molecular model for the proton transport function of 
tetrameric UCPs (Figure 4-8). Based on this model, each monomer is able to separately transport 
protons via the alternating access mechanism, with each monomer within a dimeric unit in the 
similar stages of transport. At the same time, conformational changes of one dimeric pair can 
influence the active/inactive conformation of the other pair. Considering the loose interface 
between the two dimeric pairs, we suggest that dimerization of dimers might represent a higher 
level of regulation of proton transport by UCPs. 
The study also provides more insight into the inhibition of UCPs by purine nucleotides 
(Figure 4-7 and Table 4-1), by characterizing the protein residues interacting with ATP and 
comparing it to previous studies by other researchers [63, 74, 271]. We showed that despite some 
suggestions by other researchers [63], ATP could block the internal cavity of the monomeric 
subunits (Figure 4-7), thereby not only preventing the movement of fatty acids across the protein 
but also neutralizing key arginine residues that might play critical roles in attracting fatty acids 
towards the protein.  
One approach to test the proposed model and advance our knowledge about the structure and 
function of UCPs in continuation of this work is to neutralize the suggested key amino acids by 
point mutations and to re-evaluate the structure and function. Mutations could be targeted to 
neutralize the three arginine residues in the vicinity of the matrix network (R88, R185 and R279 
for UCP2) or residues involved in the electrostatic interaction of the monomers within a dimeric 
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pair, such as K164 and E264 for UCP2. Design and synthesis of oligomerization interfering 
peptides [272] is another approach which could be used to prevent oligomerization of UCPs in 
liposomes. This method would provide the opportunity to analyze ion transport by the monomeric 
state and to study the impact of oligomerization on the proteins’ function. 
To support and complete the proposed model and to expand it to the anionic substrates of 
UCP2, chloride transport of UCP2 and the eleven mutants (Chapter 4) should be studied in future, 
and the observed trend should be compared with proton transport results. These types of analyses 
should reveal whether anions and protons are transported using the same path and provide a deeper 
understanding of the general mechanism of ion transport in UCPs. 
Finally, to gain a better knowledge about the regulation of proton transport, UCPs could be 
reconstituted together with other proton transporters of the MCF such as AAC to investigate the 
mutual impact of the two proteins on proton transport function of one another. Mutual regulatory 
impact of AAC and UCP was suggested previously as a mechanism for controlling energy in the 
cells [90]. 
Despite several advancements in understanding the structure and function of UCPs in recent 
years, there is still a considerable lack of consensus among researchers in the field. To achieve a 
commonly accepted model for the molecular and physiological behavior of UCPs in mitochondria, 
a comprehensive study is required to correlate and rectify the various models and proposed 
structures.  Historically, the source of UCPs used in biochemical and biophysical studies have been 
diverse, as UCPs were expressed and analyzed in different biological systems including bacteria, 
yeast, mammalian cell lines and animal tissues. Although time consuming, a multi-component 
research project will provide a better insight about the molecular state and function of UCPs in 


















Figure A-1-1 Sequence alignment of selected proton transporters of the human MCF, with AAC1 from 
Bovine and yeast. Alignments were generated using Jalview. Amino acids are color coded as follow: hydrophobic 
(ILVAM) coral, aromatic (FWY) orange, positive (KHR) blue, negative (DE) red, hydrophilic (STNQ) green, 
conformationally special (PG) purple and cysteine (C) yellow. Residues involved in the matrix network (red star) 
and Q-brace (red circle), cytoplasmic network (blue star) and Y-brace (blue circle), bulky residues (blue cross), 
single binding site (purple square) and the small motifs can be distinguished by their relative signs on top of the 
columns. AAC: ADP/ATP carrier, AGC: aspartate/glutamate carrier, ODC: oxoadipate carrier, CIC: citrate carrier 
or tricarboxylate carrier, ORC: ornithine carrier, UCP: uncoupling protein, PIC: phosphate carrier, GC: glutamate 
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Figure A-2-1 Schematic view of an indirect fluorescence quenching assay used for measuring the rate of 
proton transport of UCPs in liposomes. A): The SPQ fluorescent dye trapped inside vesicles can be quenched by 
TES– anions. TES– anions are generated as a consequence of an increase in the internal pH. Valinomycin directs 
potassium ions into the liposomes resulting in an uneven charge distribution (inside positive) and osmotic 
imbalance across the lipid bilayer, which causes a fatty acid-dependent UCP-mediated proton efflux. Thus, the rate 
of proton transport is indirectly measured by the rate of quenching of the SPQ fluorescence signal. B): A typical 
result for measuring proton transport using the SPQ fluorescent quenching assay. UCP-mediated Proton transport 
in the absence and presence of its inhibitor ATP, and non-specific proton flux are shown for comparison. Figure 





Appendix 3 (Chapter 3 appendix) 
Table A-3-1 Salt-bridges formed in the oligomeric UCP2 systems. a 
 




Figure A-3-1 The two interacting faces of UCP2 selected to form a dimer. The GXXXG, GXXXLXXG, and 
SmXXXSm (Sm = Gly, Ala, Ser, Thr) motifs, which promote oligomerization are shown in yellow, blue, and red, 







Figure A-3-2 Western blot analysis of AAC1 probed with α-AAC1 antibody confirms the co-presence of 
monomeric and dimeric states in OG. 
 
 
Figure A-3-3 (A – Aʹ) Protein backbone RMSD, (B – Bʹ) Rg, and (C – Cʹ) SASA for UCP2 and AAC1 in 







Figure A-3-4 Overlay of the AAC1 monomer (A-C) initial (PDB ID: 1OKC, red) and final (350 ns, blue) 





Figure A-3-5 PCA analyses for (A) monomeric, (B) dimeric, and (C) tetrameric UCP2 in POPC bilayer. 
Projection of the first 150 ns MD simulation trajectories on the first 4 eigenvectors [1st (blue), 2nd (green), 3rd 







Figure A-3-6 Visualization of PCA: Projections of the first 150 ns MD simulations on the first four eigenvectors 
for the monomeric (A – D), dimeric (Aʹ – Dʹ), and tetrameric (Aʺ – Dʺ). Blue hatching represents the direction of 
motions. Figure generated by VMD 1.9.3. 
 
 
Figure A-3-7 Initial and final structures of the dimeric (A-B) and tetrameric (C-D) UCP2 used for the 
dissociation process. Dissociation of dimer to its constituting monomers needs higher energy (18.5 kcal more) 
than dissociation of tetramer to its constituting dimers, suggesting tighter packing of monomers within the dimer 
compared to the two dimers within the tetramer. Chains 1, 2, 3 and 4 are shown in blue, red, orange and grey, 







Figure A-3-8 Main salt-bridges between the neighboring UCP2 units in a dimer of UCP2 (top panel), and 
between chains 1 and 2 (middle panel), and chains 3 and 4 (bottom panel) in a tetrameric UCP2. Chains 1, 2, 
3, and 4 are shown in blue, red, grey, and orange, respectively. Figure generated by VMD 1.9.3. 
 
 
Figure A-3-9 Distribution of the lipid head groups (phosphate) in lower (left, matrix side) and upper (right; 
cytoplasmic side) leaflets for monomeric and dimeric AAC1. As is seen, the distribution is different depending 





Appendix 4 (Chapter 4 appendix) 
 
Table A-4-1 Proton transport rate of UCP2 and its mutants in the absence and presence of 500 μM ATP. All 




Figure A-4-1 Western Blot and Coomassie blue stained semi-native SDS-PAGE analysis of purified 







Figure A-4-2 Sideview of the overall structure of tetrameric UCP2 and relative position of matrix network 


















Figure A-4-3 Top view (from the cytoplasmic side), of the final structure of (A) UCP2, (B) DN, (C) 2DN, (D) 
3DN, (E) 3KQ, and (F) Hexamutant subunits. D→N and K→Q mutations are shown in orange and yellow, 
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